$AGHI could Move Up more than +240pct! Find Out why...=====================
AGHI (Agora Holdings Inc.)
Alert Price: $0.0862
Float: 29.48M
Chart Analysis
Company Website | Recent News
========================
Members,
It's time to add a little more to this week's already impressive +59% realistic gains total!.
We ask that you please turn your immediate attention to AGHI (Agora Holdings Inc.).
We've had our eye on this highly diversified entertainment and media enterprise company for quite some time now, and it appears to be back in the buy-zone
AGHI's chart has been in a bit of a downtrend the past few days, but we feel confident that the bottom is finally in.
AGHI is looking like a picture perfect bottom'd chart bounce opportunity!
Today, AGHI closed under 10-cents for just the third time this year!
This could be the perfect entry point for traders looking to cash in on what could be AGHI's next triple-digit bullish reversal.
The last time AGHI was trading at these levels, the stock reversed hard from $0.08 all the way to a high of of $0.30.
If AGHI were to make a run back to $0.30 from today's alert price, traders would be able secure gains of up to +248%!
You will also be happy to know, that AGHI has signed some impressive contracts over the past few week's, which has us bullish heading into Q2
AGHI Subsidiary, eSilkroad Network Limited, Enters Into Contract With Sannacode to Complete Programming on Its eSilknet Platform
AGHI Subsidiary, eSilkroad Network Limited, Enters Into Formal Term Sheet With Tianjin Eastraise Business Technology Co., Ltd Securing Its First Strategic Partner in Mainland China
At just $0.0862 per share, AGHI is trading at the lower-end of its 52-week price channel, and well off its 52-week high of $0.35.
All you have to do is pull up AGHI's 6-month chart, to realize that this is the smart time to start building a position.
AGHI has broken out for big gains from these levels time and time again.
We have a feeling that AGHI's next big run-up is on the way, and we want everyone on board.
That being said, we ask that all members read our full profile, start their research now, and consider grabbing up a position in AGHI tomorrow morning at 9:30AM EST!
About Agora Holdings Inc.
Agora Holdings Inc., together with its subsidiary Geegle Media and affiliates, is presently an entertainment and media enterprise. Agora Holdings Inc. brings together media and technology, driving innovation to enhance online entertainment in five business segments: media networks, TV, studio entertainment, consumer products and interactive media. Agora is seeking to expand its portfolio to include dynamic and interactive web-based networking platforms for global implementation.
Divisions:
Esilkroad Network Limited
Esilkroad Network Limited and its subsidiary, eSilkroad of Ukraine, is a conceptual B2B platform that intends to make the interaction between businesses and non-profit organizations throughout the world faster, more effective, and less costly. eSilknet, the web-based platform under development by eSilkroad Network Limited will allow users to search for and communicate with business partners, search for and post proposals for investment and opportunity in developing projects globally, place advertisements for products and services, communicate securely on trade and project development and attract professional services for specific project-based needs. The concept of eSilknet is in line with the original concept of the “silkroad”, facilitating trade and commerce between countries, only a global scale. eSilkroad Network is currently negotiating the acquisition of complementary platform, “eSilktrade” which has been under development privately in Shanghai for several years. eSilkroad Network believes the combined expertise of its Ukraine based eSilkroad development team and the existing team at eSilktrade can integrate the live trade platform into its B2B site further enhancing value for its users. www.esilknet.com
Software Development
GEEGLE MEDIA
Geegle Media’s project management is a value-driven approach that allows the company to deliver high-priority, high-quality work and look like rock stars to their stakeholders. Its nothing like the plodding, costly and error-prone approach to project management, which has delivered inconsistent results for years.
Software projects change constantly. When customers are expected to finalize requirements before they can test-drive the prototypes, overhead and long delays often cripple the project. Geegle Media Management is about embracing change, even late in the development stage. It’s about delivering the features with the greatest business value first, and having the real-time information to tightly manage cost, time and scope.
Geegle Media Project Management reduces complexity by breaking down the many-months-long cycle of building requirements for the whole project, building the entire product and then testing to find hundreds of product flaws. Instead small, usable segments of the software product are specified, developed and tested in manageable, two- to four-week cycles.
Social Media/Marketing
FLEET
Takes Your social media campaigns to the next level!
Frame gives You full control over Your social media campaigns
Login using Facebook Login using Twitter Login using Instagram
Manage all of Your social media channels in one place
Schedule your posts for the right time
Prepare your posts and prepare their share in the future.
Save time and efforts.
Publish posts on all social accounts you need.
Generate professional infographic reports
Use their analytic tools to generate professional presentations for social media performance in special designed templates
Follow your best friends more intensive
Follow what your social media friends upload and choose what posts to see
Recent Developments
Agora Holdings Inc. Subsidiary, eSilkroad Network Limited, Enters Into Contract With Sannacode to Complete Programming on Its eSilknet Platform
On Tuesday, the Company announced that its controlled subsidiary, eSilkroad Network Limited (“ESR”) of Hong Kong, has completed prototype testing and focus groups during January and early February 2019, whereby over 300 corporations were exposed to our landing page prototypes. With testing complete, ESR has retained Sannacode (sannacode.com) to conclude programming of our final platform. Sannacode is a multi-disciplinary company that specializes in web design and development.
Sannacode designs, develops, tests and maintains digital products ranging from web, mobile, games and wearable technologies. Headquartered in Kiev, Sannacode works with companies in every continent around the world. Their management team reflects the talent and focus to bring clarity to corporate visions including creating customized solutions for ESR. The Sannacode team offers a combined 30 years of experience in design, development and testing.
ESR President Oleg Sytnyk commented, “We are extremely excited to be working with Sannacode to complete the final phase of our platform development. Their firm is uniquely qualified to deliver the high level of functionality and design we wish to present in our final commercial site.”
Market Outlook
The social media market has been hot for the past few years. Companies have realized social media could be one of the main drivers of growth. However, with the Facebook scandal, it’s opened the market up for new competitors to join in on the action.
According to Research and Markets, B2B e-commerce sales are forecast to be over two times higher than global online retail sales. That said, there is immense growth potential in the market.
A report from Forrester Research in 2017 estimated business-to-business (B2B) ecommerce transactions would reach $1.2 trillion by 2021.
Frost & Sullivan has even loftier expectations with B2B ecommerce hitting $6.6 trillion by 2020.
Over 400,000 organizations are already shopping on Amazon Business with B2B.
Technical Analysis
As we enthusiastically stated above, AGHI has a well recorded history of breaking out big from these exact levels..
The last time AGHI was trading at these levels, the stock reversed hard from $0.08, all the way to a high of of $0.30.
If AGHI were to make a run back to $0.30 from today's alert price, traders would be able secure gains of up to +248%!
We've done our very own chart analysis, and see the potential for a move of +60%-100%!
But remember, AGHI's trading history has shown us multi-day rallies of much more than that.
All you have to do is pull up AGHI's 6-month chart, to realize that this is the smart time to start building a position.
AGHI has broken out for big gains from these levels time and time again.
We have a feeling that AGHI's next big run-up is on the way, and we want everyone on board.
As such, we are urging all members to start their research now, and consider grabbing up a position in AGHI tomorrow morning at 9:30AM EST!
(*Remember to use a basic Stop-Loss Order or more advanced Stop-limit Order to protect your gains, as well as limit possible losses.)
Best Regards,
The TopMarketGainers Team
Don't Miss Our Next Huge Winner...
Text 'GAINS' to '67076'
to have our Trade Alerts
Delivered Direct
to your Cell Phone.
(There is no charge.
Msg&data rates may apply.)
Follow Us On Twitter:
DISCLAIMER
This newsletter is a paid advertisement, not a recommendation nor an offer to buy or sell securities. This newsletter is owned, operated and edited by both MJ Capital, LLC and PennyStockLocks, LLC. Any wording found in this e-mail or disclaimer referencing to “I” or “we” or “our” refers to MJ Capital, LLC and PennyStockLocks, LLC. Our business model is to be financially compensated to market and promote small public companies. By reading our newsletter and our website you agree to the terms of our disclaimer, which are subject to change at any time. We are not registered or licensed in any jurisdiction whatsoever to provide investing advice or anything of an advisory or consultancy nature, and are therefore are unqualified to give investment recommendations. Always do your own research and consult with a licensed investment professional before investing. This communication is never to be used as the basis of making investment decisions, and is for entertainment purposes only. At most, this communication should serve only as a starting point to do your own research and consult with a licensed professional regarding the companies profiled and discussed. Conduct your own research. Companies with low price per share are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold our site, its editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters or on our website.
We do not advise any reader take any specific action. Losses can be larger than expected if the company experiences any problems with liquidity or wide spreads. Our website and newsletter are for entertainment purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter and on our website may be based on end-of-day or intraday data. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. If we own any shares we will list the information relevant to the stock and number of shares here. MJ Capital does NOT own any shares of the companies mentioned herewithin, nor intends to buy any in the future.
MJ Capital’s business model is to receive financial compensation to promote public companies. We have been compensated ten thousand dollars by ACN LLC. to conduct investor relations advertising and marketing for AGHI. We have been previously compensated ten thousand dollars by ACN LLC. to conduct investor relations advertising and marketing for AGHI on two seperate occassions -which have expired. Any compensation is a major conflict of interest in our ability to be unbiased. Therefore, this communication should be viewed as a commercial advertisement only. We have not investigated the background of the hiring third party or parties. The third party, profiled company, or their affiliates likely wish to liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices. Any non-compensated alerts are purely for the purpose of expanding our database for the benefit of our future financially compensated investor relations efforts. Frequently companies profiled in our alerts may experience a large increase in volume and share price during the course of investor relations marketing, which may end as soon as the investor relations marketing ceases. The investor relations marketing may be as brief as one day, after which a large decrease in volume and share price is likely to occur. Our emails may contain forward looking statements, which are not guaranteed to materialize due to a variety of factors.
We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters and on our website is believed to be accurate and correct, but has not been independently verified and is not guaranteed to be correct. The information is collected from public sources, such as the profiled company’s website and press releases, but is not researched or verified in any way whatsoever to ensure the publicly available information is correct. Furthermore, MJ Capital often employs independent contractor writers who may make errors when researching information and preparing these communications regarding profiled companies. Independent writers’ works are double-checked and verified before publication, but it is certainly possible for errors or omissions to take place during editing of independent contractor writer’s communications regarding the profiled company(s). You should assume all information in all of our communications is incorrect until you personally verify the information, and again are encouraged to never invest based on the information contained in our written communications. The information in our disclaimers is subject to change at any time without notice.
Undervalued
BHTG is our low-float Nasdaq listed alert w/ Growing Revenues + BHTG is our low-float Nasdaq listed alert w/ Growing Revenues + Fortune 500 Clients
=====================
BHTG (Bio Hi Tech Global Inc.)
Current Price: $2.25
Analyst Price Target: $7.00
Float: 6.63 M
Chart Analysis
Investor Presentation
Website | Recent News
========================
Members,
We hope you enjoyed the nearly +41% in realistic gains that today's alert provided.
We're not wasting anytime with our next pick, as we have found an incredible opportunity trading on the Nasdaq.
Please turn your immediate attention to BHTG (Bio Hi Tech Global Inc.).
It may not be the most exciting sector on the market, but there is no denying that waste management is an extremely lucrative industry.
According to a new report published by Allied Market Research, titled,"Waste Management Market by Waste Type and Service: Global Opportunity Analysis and Industry Forecast, 2018 - 2025,"the global waste management market accounted for $303.6 billion in 2017, and is expected to reach $484.9 billion by 2025, growing at a CAGR of 6.0% from 2018 to 2025".
With its cutting edge technology, BHTG appears to be well on its way to changing the game in this multi-billion dollar industry.
Trading at a nearly sixty-one percent discount from its 52-week high, BHTG looks like one of the biggest steals on the Nasdaq at the moment.
For one, its client list already reads like a veritable "Who's Who" in the service industry:
The Cheese Cake Factory
Costco
Dunk in Donuts
Golden Corral
Hilton
Marriott
The Hard Rock Cafe
These are all global household names whose growth could be considered an immediate catalyst for BHTG's bottom line.
Find out why $VICA could see Another +60pct Move... TOMORROW!=====================
VICA (Rafina Innovations Inc.)
Current Price: $0.3150
Float: 3.91M
Chart Analysis
Website | Recent News
========================
Members,
A fresh trading week is upon us, and we have identified the perfect pick to kick it off with.
Please turn your immediate attention to VICA (Rafina Innovations Inc.).
Just like many of our recent winners, VICA trades on the OTC-QB, and has a tiny float of just 3.91M
This is an exciting time for VICA, as the Company has gone through a rebranding period in order to better reflect their business objectives.
Their revolutionary Flexisense™ technology has found demand for applications in many more industry sectors than was initially anticipated, and their portfolio of technologies have grown to include a much broader scope of innovations with application across numerous fields, including many outside the medical technology segment.
In addition to healthcare technology, VICA is currently involved with projects related to Human Augmentation, Automotive safety and Smart Homes.
One such project could be a game-changer in a multi-billion dollar market.
VICA is currently developing cutting prototype for sleep apnoea through a biPAP machine that the Company's management believes can positively impact those with sleep apnoea, a respiratory failure which occurs during sleep.
We see this as a major revenue generating opportunity for VICA.
The sleep apnoea devices market is projected to reach USD 6.49 Billion by 2023 from an estimated USD 4.44 Billion in 2018, at a CAGR of 7.8%!
VICA is another one of those tickers that could go viral in minutes, and has a history of tremendous single-day breakouts.
In fact, just last week it ran up nearly +60% in just one session.
We've done our own chart analysis, and see the potential for a move of up to +195%.
This has the potential to be the next big winner for our members, and we want to see everyone on board.
As such, we are urging all members to read our full profile on VICA, start their research now, and to add it to the top of their watchlist!
About Rafina Innovations Inc.
Rafina Innovations Inc. operates two fully owned subsidiaries: 1. HCi Viocare Technologies: developing hardware solutions aiming to empower the user by providing on demand information and enhancing living quality. The R&D center located in Glasgow, Scotland, is working on a large portfolio of cutting edge, revolutionary and disruptive technologies in the fields of Digital Health, Prosthetics, Orthotics, Diabetes, Assistive Devices, Sports & Wellbeing, and DVT. The Company has developed a unique sensing technology with the brand name Flexisense™, which uses a multitude of micro sensors to detect pressure as well as shear that is unique over other sensing technologies. The sensors are wirelessly connected to smart devices providing real time and on demand information. HCi Viocare Technologies works on a licensing business model. 2. HCi Viocare Clinics: creating the first cross-border independent chain of Prosthetics & Orthotics (P&O) and Diabetic Foot clinics in Europe.
HCi Viocare’s Glasgow clinic is a subsidiary of HCi Viocare. Its founders Sotiris Leontaritis, a highly experienced entrepreneur and Dr Christos Kapatos, a Prosthetics and Orthotics expert and inventor, share a vision to improve people’s wellbeing in the face of a growing and correlated population of the obese, diabetic, amputated and/or movement impaired. To this end, HCi Viocare is establishing a chain of Prosthetic, Orthotic and diabetic foot rehabilitation centres in addition to implementing bioengineering innovations research and development in view of gaining licensing for health and wellness sectors.
This Glasgow clinic, the only private P&O clinic in Scotland, is HCi Viocare’s first. It has evolved from the private practice of Bill Spence CPO, MBAPO, MISPO Certified Prosthetist Orthotist, founder and former chairman of the Association of Prosthetists and Orthotists (now BAPO) and former Chief of Research in Blatchford’s Clinical Services. Mr Spence played an integral role in the set-up of the rehabilitation suite and workshop, and hand-picked the P&O team responsible for client care.
The clinic will serve as a key reference point and training centre for the HCi Viocare group of clinics, exporting British and International standards of care to under-served regions in the Mediterranean and Middle East. With a view to ensuring excellent practices and care, the company is supported by Professor Stephan Solomonidis, Bioengineer, F.I.MechE at the University of Strathclyde who, during his longstanding research and academic career has substantially contributed to the P&O International standards. Both Mr Spence and Prof Solomonidis supervised the company’s co-founder Dr Kapatos in obtaining his PhD at the University of Strathclyde, a globally renowned centre of excellence in bio-engineering.
Please visit:
www.rafinainnovations.com
www.hci-viocare.co.uk
Recent Developments for VICA
Rafina Innovations Begins Development on a Prototype for Sleep Apnoea
On February 14th, the Company announced that it recently commenced development on a prototype for sleep apnoea through a biPAP machine that management believes can positively impact those with sleep apnoea, a respiratory failure which occurs during sleep.
Constantinos Zertalis, Rafina’s Chairman, President and CEO, commented: "Our research shows that 1 in 6 people suffer from respiratory failure that requires a biPAP machine. Further, solutions currently in the marketplace include equipment that tends to be large in size. Following investigation into the marketspace and needs of the consumer, our research and development team believe we can produce biPAP equipment that can be small in size, travel friendly and also energy efficient. Management expects the prototype to be ready between three to six months, and approximately the same size as a mobile phone. We believe our vision of this essential product will be attractive to the current market due to its small size, without sacrificing functionality, making it extremely convenient for users.”
Market Outlook:
The sleep apnoea devices market is projected to reach USD 6.49 Billion by 2023 from an estimated USD 4.44 Billion in 2018, at a CAGR of 7.8%. Growth in this market can primarily be attributed to factors such as the increasing prevalence of sleep apnoea globally owing to the increase of lifestyle diseases like obesity, initiatives by market players and the government to increase awareness regarding sleep apnoea, and the various technological advancements brought about by players to make the products comfortable for patients and thus increase patient compliance and adherence to the treatment.
Technical Analysis:
We love these low-float alerts, and their potential to breakout for monster single-day gains.
Last week we watched VICA jump nearly +60% in just one session.
Shares of VICA ran up from $0.24 to $0.38 last Thursday on light trade volume.
With its low-float of just 3.91M, a nice boost in volume could send shares of VICA soaring ever higher than what we witnessed last Thursday.
VICA was trading at over $1.00 less than 6-months ago.
A run back to a dollar from today's alert price would show traders gains of over +212%!
As we've mentioned above, we've done our own chart analysis, and see the potential for a move of up to +195%.
We are anticipating another huge day for VICA tomorrow.
This has the potential to be the next triple-digit gainer for our members.
As such, we are urging all members to start their research on VICA, and to add it to the top of their watchlist!
Best Regards,
The TopMarketGainers Team
Don't Miss Our Next Huge Winner...
Text 'GAINS' to '67076'
to have our Trade Alerts
Delivered Direct
to your Cell Phone.
(There is no charge.
Msg&data rates may apply.)
Follow Us On Twitter:
twitter.com
DISCLAIMER
This newsletter is a paid advertisement, not a recommendation nor an offer to buy or sell securities. This newsletter is owned, operated and edited by both MJ Capital, LLC and PennyStockLocks, LLC. Any wording found in this e-mail or disclaimer referencing to “I” or “we” or “our” refers to MJ Capital, LLC and PennyStockLocks, LLC. Our business model is to be financially compensated to market and promote small public companies. By reading our newsletter and our website you agree to the terms of our disclaimer, which are subject to change at any time. We are not registered or licensed in any jurisdiction whatsoever to provide investing advice or anything of an advisory or consultancy nature, and are therefore are unqualified to give investment recommendations. Always do your own research and consult with a licensed investment professional before investing. This communication is never to be used as the basis of making investment decisions, and is for entertainment purposes only. At most, this communication should serve only as a starting point to do your own research and consult with a licensed professional regarding the companies profiled and discussed. Conduct your own research. Companies with low price per share are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold our site, its editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters or on our website.
We do not advise any reader take any specific action. Losses can be larger than expected if the company experiences any problems with liquidity or wide spreads. Our website and newsletter are for entertainment purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter and on our website may be based on end-of-day or intraday data. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. If we own any shares we will list the information relevant to the stock and number of shares here. MJ Capital does NOT own any shares of the companies mentioned herewithin, nor intends to buy any in the future.
MJ Capital’s business model is to receive financial compensation to promote public companies. We have been compensated ten thousand dollars by s 3rd party to conduct investor relations advertising and marketing for VICA. Any compensation is a major conflict of interest in our ability to be unbiased. Therefore, this communication should be viewed as a commercial advertisement only. We have not investigated the background of the hiring third party or parties. The third party, profiled company, or their affiliates likely wish to liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices. Any non-compensated alerts are purely for the purpose of expanding our database for the benefit of our future financially compensated investor relations efforts. Frequently companies profiled in our alerts may experience a large increase in volume and share price during the course of investor relations marketing, which may end as soon as the investor relations marketing ceases. The investor relations marketing may be as brief as one day, after which a large decrease in volume and share price is likely to occur. Our emails may contain forward looking statements, which are not guaranteed to materialize due to a variety of factors.
We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters and on our website is believed to be accurate and correct, but has not been independently verified and is not guaranteed to be correct. The information is collected from public sources, such as the profiled company’s website and press releases, but is not researched or verified in any way whatsoever to ensure the publicly available information is correct. Furthermore, MJ Capital often employs independent contractor writers who may make errors when researching information and preparing these communications regarding profiled companies. Independent writers’ works are double-checked and verified before publication, but it is certainly possible for errors or omissions to take place during editing of independent contractor writer’s communications regarding the profiled company(s). You should assume all information in all of our communications is incorrect until you personally verify the information, and again are encouraged to never invest based on the information contained in our written communications. The information in our disclaimers is subject to change at any time without notice.
LONG $IONI @ $.16 - I-ON Communication Corp UpsideTechnical Analysis:
- Potential Double Bottom price support at $.15 from 2/15/19.
- Extremely Oversold on weekly/monthly timeframes.
- Daily/Weekly RSI and MACD turning up while prices are moving lower, conveying negative divergence and potential trend reversal.
- Prices breaking above short-term daily moving averages (10dayEMA and 21daySMA @ $.24).
Fundamental Analysis:
- Price to book ratio <1 conveys undervaluation: I-ON Communications current stock price is $0.16 and Book Value per Share for the quarter that ended in Sep. 2018 was $0.17, therefore I-ON Communications Corp's P/B Ratio is 0.95. This conveys undervaluation by that I-ON's assets ($6 Million) are worth more than the current market cap of the company (5 Million).
- Price to sales ratio <1 conveys undervaluation as most high growth emerging technology companies trade at a 4-5x revenue multiple.
- Domestic market share leader and one of few technology or software companies to emanate out of South Korea and conduct a US listing directly onto the OTCQX.
- Multiple patent-backed enterprise products and solutions at market with blue-chip clientele across South Korea and Japan (100s of clients).
- Room for significant gross and operating margin improvement via sales mix improvements including more licensing and SaaS contribution.
- First mover advantage playing into several attractive high growth industries, including sports software, energy IoT, as well as cloud-based CMS and SaaS solutions conveying revenue stream diversity.
The #BitcoinSV | $BSV rocket is ready to Moon... SOON!Without further ado...
=======================
Our New Pick is: BSV/USDT,
BSV/BTC
Exchange: Coinbase,
Robinhood,
Bitfinex, Binance
Dollar Price: $65/$67
(Exchange Prices Differ)
Bitcoin Price: .01654/btc
Circulating Supply: 17.6M
==========================
Members,
We're following up Wednesday's profitable EOS /usdt alert with a even more lucrative opportunity!
BSV/USDT | BSV/BTC is sitting at the magic 0.7 fibonacci zone and appears to be setup for a perfect Elliott Wave, wave 2 to 3 impulse move!
About the Company:
Bitcoin SV is the original Bitcoin. It restores the original Bitcoin protocol, will keep it stable, and allow it to massively scale. Bitcoin SV will maintain the vision set out by Satoshi Nakamoto’s white paper in 2008: Bitcoin: A Peer-to-Peer Electronic Cash System
Reflecting its mission to fulfil the vision of Bitcoin, the project name represents the “Satoshi Vision” or SV. Created at the request of leading BSV mining enterprise CoinGeek and other miners, Bitcoin SV is intended to provide a clear choice for miners and allow businesses to build applications and websites on it reliably.
Bitcoin SV restores the original vision to ignite the future of Bitcoin:
Bitcoin, as restored in Bitcoin SV can replace every payment system in the world with a better user experience, a cheaper merchant cost, and a safer level of security.
Businesses can trust the Bitcoin SV brand to provide the stability and scale they need to commit investment and resources to use the BSV blockchain.
Click here to read more on BitcoinSV(Satoshi Vision).
Technical Analysis (TA):
Click here to view the INTERACTIVE CHART on TradingView.com.
If you were wondering why do we trade Altcoins rather than Bitcoin? The answer is simple.
Altcoins are more volatile and provide a larger profit margin than Bitcoin.
Remember - the overall direction of Bitcoin and other cryptocurrencies are extremely hard to predict, therefore we like to offer our subscribers both Bullish and Bearish perspectives.
With regard to that, we highly recommend that you use Stop-loss Orders to protect gains, as well as limit possible losses, when trading these highly volatile digital assets.
Best Regards,
The CryptoCurrencyAlerts Team
Don't Miss Our Next Huge Winner...
Text 'COINS' to '67076'
to have our Trade Alerts
Delivered Direct
to your Cell Phone.
(There is no charge.
Msg&data rates may apply.)
DISCLAIMER
This newsletter is a paid advertisement, not a recommendation nor an offer to buy or sell securities. This newsletter is owned, operated and edited by both MJ Capital, LLC and PennyStockLocks, LLC. Any wording found in this e-mail or disclaimer referencing to “I” or “we” or “our” refers to MJ Capital, LLC and PennyStockLocks, LLC. Our business model is to be financially compensated to market and promote small public companies. By reading our newsletter and our website you agree to the terms of our disclaimer, which are subject to change at any time. We are not registered or licensed in any jurisdiction whatsoever to provide investing advice or anything of an advisory or consultancy nature, and are therefore are unqualified to give investment recommendations. Always do your own research and consult with a licensed investment professional before investing. This communication is never to be used as the basis of making investment decisions, and is for entertainment purposes only. At most, this communication should serve only as a starting point to do your own research and consult with a licensed professional regarding the companies profiled and discussed. Conduct your own research. Companies with low price per share are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold our site, its editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters or on our website.
We do not advise any reader take any specific action. Losses can be larger than expected if the company experiences any problems with liquidity or wide spreads. Our website and newsletter are for entertainment purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter and on our website may be based on end-of-day or intraday data. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. If we own any coins/tokens/shares we will list the information relevant to the stock and number of shares here. The owners of this newsletter own/trade Bitcoin(s), and are currently holding a LONG position as much as 500 BitcoinSV | BSV; & we reserve the right to buy or sell their coins/tokens at any time in the future without notice.
Our business model is to receive financial compensation to promote public companies. Any compensation is a major conflict of interest in our ability to be unbiased. Therefore, this communication should be viewed as a commercial advertisement only. We have not investigated the background of the hiring third party or parties. The third party, profiled company, or their affiliates likely wish to liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices. Any non-compensated alerts are purely for the purpose of expanding our database for the benefit of our future financially compensated investor relations efforts. Frequently companies profiled in our alerts may experience a large increase in volume and share price during the course of investor relations marketing, which may end as soon as the investor relations marketing ceases. The investor relations marketing may be as brief as one day, after which a large decrease in volume and share price is likely to occur. Our emails may contain forward looking statements, which are not guaranteed to materialize due to a variety of factors.
We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters and on our website is believed to be accurate and correct, but has not been independently verified and is not guaranteed to be correct. The information is collected from public sources, such as the profiled company’s website and press releases, but is not researched or verified in any way whatsoever to ensure the publicly available information is correct. Furthermore, we often employs independent contractor writers who may make errors when researching information and preparing these communications regarding profiled companies. Independent writers’ works are double-checked and verified before publication, but it is certainly possible for errors or omissions to take place during editing of independent contractor writer’s communications regarding the profiled company(s). You should assume all information in all of our communications is incorrect until you personally verify the information, and again are encouraged to never invest based on the information contained in our written communications. The information in our disclaimers is subject to change at any time without notice.
NAKD is back on high alert. Low-float, Nasdaq-listed company...=====================
NAKD (Naked Brand Group Limited)
Current Price: $0.3947
Float: 8.34M
Investor Presentation
Chart Analysis
Website | Recent News
========================
Members,
The up to +18% in realistic gains that today's trade idea delivered was the perfect way to start this shortened trading week.
Now it's time to swing for the fences!
Please turn your immediate attention to NAKD (Naked Brand Group Limited).
Those of you that have been following us for awhile, know that NAKD has been one of our favorite/most profitable tickers of all-time.
We first brought this Nasdaq-listed company to your attention back on 7/8/16 when it was trading at $1.37.
Within 6-months shares had climbed over +168% from our alert price.
NAKD then took its place as one of our largest long-term gainers of all-time, when it hit a high of $11.36 on June 20th, 2018.
Since then, NAKD has been in a downtrend...
But we have good news....
It appears that the bottom is finally in!
After hitting an all-time low of $0.31 last Friday, shares of NAKD have held strong, and it looks like we may have an epic reversal in the making.
NAKD closed today's session up nearly 3 percent, and as of right now shares of NAKD are up nearly five percent in after-hours trading!
This after-hours action has us extremely bullish heading into tomorrow's trading session.
One thing we've learned over time, is that NAKD is the kind of ticker that can go viral in minutes
In fact, in just the past six months, we've witnessed shares of NAKD run-up over +40% on four separate occasions.
Our current chart analysis shows the potential for a triple-digit move.
With its low-float of just 8.34M, a nice boost in volume could send shares of NAKD soaring early, and if the Company releases any market friendly news.........Prepare for fireworks!
We are anticipating another huge day for NAKD.
This could be one of the biggest gainers on the Nasdaq tomorrow.
As such, we are urging all members to read our full profile on NAKD, start their research, and to add it to the top of their watchlist!
About Pressure Naked Brand Group Limited
Naked Brand Group Limited (NAKD) is a leading intimate apparel and swimwear company with a diverse portfolio of brands. The company designs, manufactures and markets a portfolio of 11 company-owned and licensed brands, catering to a broad cross-section of consumers and market segments. Brands include Naked, Bendon, Bendon Man, Davenport, Fayreform, Hickory, Lovable, Pleasure State, Heidi Klum Intimates, Heidi Klum Man, Heidi Klum Swim. Naked Brand Group Limited products are available in 44 countries worldwide through 6,000 retail doors, a growing network of E-commerce sites and 61 company-owned Bendon retail and outlet stores in Australia and New Zealand. Brands are distributed through premier department stores, specialty stores, independent boutiques and third-party e-commerce sites globally, including Macy’s, Nordstrom, Saks Fifth Avenue, Harrods, Selfridges, Amazon and ASOS among others. For more information please visit www.nakedbrands.com.
Investment Highlights
Management believes the Company is positioned for accelerated growth in 2019!
Scalable business model with a large, global revenue footprint
Iconic brand and product portfolio, including an evergreen partnership with Heidi Klum
Launched Heidi Klum Intimates Solutions line to over 4,000 CVS locations across the United States.
Acquired several Tier 1 retail relationships including Bloomingdales, Nordstrom and Dilliards
Closed merger transaction between Naked Brand Group and the internationally recognized Bendon Limited creates a unique retail operating platform capable of supporting USD$200m in revenue with minimal growth in G&A
Completed acquisition of Fredericks of Hollywood Global E-Commerce Licensee, FOH Online Corp.
In-store experience and store operations supplementing growing eCommerce sales
Concurrent debt restructuring and equity financing fortifies balance sheet and enables the realization of new supply chain cost savings
Public vehicle provides opportunity to leverage stock when opportunistic acquiring new brands
There is a significant opportunity to consolidate a fragmented global marketplace which is expected to grow to USD $250B by 2022
Experienced management team with deep industry experience
Recent Developments for NAKD
Naked Brand Group Limited Reports First Half Fiscal 2019 Financial Results
Key First Half Fiscal 2019 Financial Highlights:
Net sales for the first half of 2019 decreased by 5.1% to NZD$56.8 million, or USD$38.6 million, compared to NZD$59.8 million, or USD$40.6 million, for the first half of 2018.
Gross profit margin as a percentage of revenue decreased to 31.2% in the first half of 2019, as compared to approximately 32.7% in the first half of 2018.
Operating expenses increased to NZD$43.7 million, or USD$29.7 million, in the first half of 2019, compared to NZD$38.8 million, or USD$26.4 million, in the first half of 2018. The increase in operating expenses was due to the costs incurred as part of the U.S. listing process NZD$5.1million or USD $3.5 million as well as non-cash impairment charges of NZD$4.1 million or USD$2.8 million.
Net loss totaled NZD$26.5 million, or USD$18.07 million, in the first half of 2019, or (NZD$1.28), or (USD$0.87), per basic and diluted share, compared to a net loss of NZD$18.42 million, or USD$12.5 million, in the first half of 2018, or (NZD$0.89), or (USD$0.61), per basic and diluted share.
Adjusted EBITDA loss totaled NZD$15.4million, or USD$10.5 million, in the first half of 2019 compared to the first half of 2018 of adjusted EBITDA loss of NZD$16.2million or USD$11.0million.
Key First Half Fiscal 2019 and Subsequent Operational Highlights:
Completed merger between Naked Brand Group Inc. and Bendon Limited creating a global leader in intimate apparel and swimwear.
Completed debt restructuring and equity financing to fortify balance sheet and realize new supply chain cost savings.
Appointed veteran apparel executives to accelerate rapidly growing e-commerce channel.
Completed agreement with CVS Health and launched Heidi Klum Intimates Solutions line to over 4,000 CVS locations across the United States.
Launched new Diffusion program nationwide with Costco Wholesale Australia.
Launched retail and outlet store expansion strategy across Australia and New Zealand.
Completed acquisition of Fredericks of Hollywood global e-commerce licensee, through the purchase of FOH Online Corp.
Management Commentary
“The first half fiscal 2019 was a very pivotal time for the newly combined company as we integrated both businesses, cleaned up our capital structure and eliminated some divisions in order to position Naked for the next phase of our e-commerce business,” said Justin Davis-Rice, CEO of Naked. “While today’s reported financial results reflect a period of transition, we believe the steps taken during this time will position the company for accelerated growth in the new year. We look forward to updating shareholders on these developments and new pending initiatives in early 2019 on our rescheduled conference call,” concluded Davis-Rice.
First Half Fiscal 2019 Financial Results
Net sales in the first half of 2019 totaled NZD$56.8 million, or USD$38.6 million, a decrease of 5.1% compared to NZD$59.8 million, or USD$40.6 million, in the first half of 2018. This decrease in net sales was primarily a result of vendor supply issues.
Gross profit totaled approximately NZD$17.7 million, or USD$12.1 million, in the first half of 2019 as compared to NZD$19.6 million, or USD$13.3 million, in the first half of 2018. Gross profit margin as a percentage of revenue decreased to 31.2% in the first half of 2019, as compared to approximately 32.7% in the first half of 2018. The reduction in gross margin was caused by increased discounts provided to customers and sub-optimal stock mix due to the vendor supply issue.
Operating expenses increased to NZD$43.7 million, or USD$29.7 million, in the first half of 2019, compared to NZD$38.8 million, or USD$26.4 million, in the first half of 2018.
Net loss totaled NZD$26.5 million, or USD$18.07 million, in the first half of 2019, or (NZD$1.28), or (USD$0.87), per basic and diluted share, compared to a net loss of NZD$18.42 million, or USD$12.5 million, in the first half of 2018, or (NZD$0.89), or (USD$0.61), per basic and diluted share . The increase in net loss was due to reduced gross profit and increased expenses.
Adjusted EBITDA loss decreased to NZD$15.4 million, or USD$10.5 million, in the first half of 2019 from NZD$16.3 million, or USD$11.1 million, in the first half of 2018. See below under the heading “Use of Non-GAAP Financial Information” for a discussion of EBITDA and a reconciliation of such measure to the most comparable measure calculated under U.S. generally accepted accounting principles ("GAAP").
Cash and cash equivalents at July 31, 2018 totaled NZD$4.2 million, or USD$2.9 million, as compared to $3.5 million, or USD$2.4 million, at July 31, 2017. Subsequent to the closing of the first half fiscal 2019, the company completed a USD$3.4 million private placement of ordinary shares and warrants with two accredited investors, including Naked CEO, Justin Davis-Rice.
The New Zealand Dollar figures in this press release were converted to United States Dollar figures at an 0.68 exchange rate.
Further details about the Company’s results in the first half 2019 are available on Form 6-K, which can be viewed by clicking here.
Market Outlook:
The global intimate wear market is expected to grow to $250 billion by 2022
The global underwear, hosiery and sports and swimwear market is expected to grow from $348b in 2017 to more than $416B in 2021
The average amount spent annually on Underwear, Hosiery and Sports and Swimwear is expected to grow 17% to $79.57 per capita in 2021
Consumers are not only purchasing more underwear (8 pieces per capita annually in 2017 compared to 6 in 2010), but they are spending more as well, with the average price per unit increasing 11% since 2010
Technical Analysis:
We love these low-float, Nasdaq listed alerts, and NAKD has proven itself time and time again to be a significant winner for our members.
Traders now have the opportunity to grab up shares of NAKD at its near all-time low.
After hitting its all-time low of $0.31 last Friday, shares of NAKD have held strong, and it looks like we may have an epic reversal in the making.
One thing we've learned over time, is that NAKD is the kind of ticker that can go viral in minutes
In fact, in just the past six months, we've witnessed shares of NAKD run-up over +40% on four separate occasions.
Our current chart analysis shows the potential for a triple-digit move.
With its low-float of just 8.34M, a nice boost in volume could send shares of NAKD soaring early.
Shares of NAKD were trading as high as $11.36 just under 8-months ago.
A run back to those highs from today's alert price would show traders gains of over +2,778%!
NAKD closed today's session up nearly 3 percent, and as of right now shares of NAKD are up nearly five percent in after-hours trading!
This after-hours action has us extremely bullish heading into tomorrow's trading session.
We are anticipating another huge day for NAKD.
This could be one of the biggest gainers on the Nasdaq tomorrow.
As such, we are urging all members to start their research on NAKD, and to add it to the top of their watchlist!
Best Regards,
The TopMarketGainers Team
Don't Miss Our Next Huge Winner...
Text 'GAINS' to '67076'
to have our Trade Alerts
Delivered Direct
to your Cell Phone.
(There is no charge.
Msg&data rates may apply.)
DISCLAIMER
This newsletter is a paid advertisement, not a recommendation nor an offer to buy or sell securities. This newsletter is owned, operated and edited by both MJ Capital, LLC and PennyStockLocks, LLC. Any wording found in this e-mail or disclaimer referencing to “I” or “we” or “our” refers to MJ Capital, LLC and PennyStockLocks, LLC. Our business model is to be financially compensated to market and promote small public companies. By reading our newsletter and our website you agree to the terms of our disclaimer, which are subject to change at any time. We are not registered or licensed in any jurisdiction whatsoever to provide investing advice or anything of an advisory or consultancy nature, and are therefore are unqualified to give investment recommendations. Always do your own research and consult with a licensed investment professional before investing. This communication is never to be used as the basis of making investment decisions, and is for entertainment purposes only. At most, this communication should serve only as a starting point to do your own research and consult with a licensed professional regarding the companies profiled and discussed. Conduct your own research. Companies with low price per share are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold our site, its editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters or on our website.
We do not advise any reader take any specific action. Losses can be larger than expected if the company experiences any problems with liquidity or wide spreads. Our website and newsletter are for entertainment purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter and on our website may be based on end-of-day or intraday data. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. If we own any shares we will list the information relevant to the stock and number of shares here. MJ Capital does NOT own any shares of the companies mentioned herewithin, nor intends to buy any in the future.
MJ Capital’s business model is to receive financial compensation to promote public companies. We have been compensated ten thousand dollars by World Wide Holdings dba Invictus Resources to conduct investor relations advertising and marketing for NAKD. We have previously been compensated ten thousand dollars by World Wide Holdings dba Invictus Resources to conduct investor relations advertising and marketing for NAKD- which has expired. Any compensation is a major conflict of interest in our ability to be unbiased. Therefore, this communication should be viewed as a commercial advertisement only. We have not investigated the background of the hiring third party or parties. The third party, profiled company, or their affiliates likely wish to liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices. Any non-compensated alerts are purely for the purpose of expanding our database for the benefit of our future financially compensated investor relations efforts. Frequently companies profiled in our alerts may experience a large increase in volume and share price during the course of investor relations marketing, which may end as soon as the investor relations marketing ceases. The investor relations marketing may be as brief as one day, after which a large decrease in volume and share price is likely to occur. Our emails may contain forward looking statements, which are not guaranteed to materialize due to a variety of factors.
We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters and on our website is believed to be accurate and correct, but has not been independently verified and is not guaranteed to be correct. The information is collected from public sources, such as the profiled company’s website and press releases, but is not researched or verified in any way whatsoever to ensure the publicly available information is correct. Furthermore, MJ Capital often employs independent contractor writers who may make errors when researching information and preparing these communications regarding profiled companies. Independent writers’ works are double-checked and verified before publication, but it is certainly possible for errors or omissions to take place during editing of independent contractor writer’s communications regarding the profiled company(s). You should assume all information in all of our communications is incorrect until you personally verify the information, and again are encouraged to never invest based on the information contained in our written communications. The information in our disclaimers is subject to change at any time without notice.
$PBIO makes CBD Oil Water Soluble. This Could Impact a $22B..==============================
PBIO (Pressure Bio Sciences Inc.)
Current Price: $3.05
Investor Presentation
Chart Analysis
Website | Recent News
========================
Members,
We hope you are enjoying this long weekend, and much deserved time off.
As many of you know, we are coming off an amazing week of trading, which included over +182% in realistic gains.
One company that made a major contribution to that impressive gains totals was PBIO (Pressure Bio Sciences Inc.).
We first brought PBIO to your attention last Wednesday, and watched it deliver over +51% in realistic gains in just one trading session.
We continue to love the growth potential of this highly innovative company.
Based on our chart analysis and current market conditions, we still believe that PBIO has plenty of room to run from here, and should remain on the very top of your watchlist.
About Pressure BioSciences, Inc.
Pressure Bio Sciences, Inc. (PBIO) is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences industry. Their products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or "PCT") hydro static pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydro static pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions (e.g., cell lysis, bio molecule extraction). Their primary focus is in the development of high pressure-based products for bio marker and target discovery, drug design and development, bio therapeutics characterization and quality control, food science, soil & plant biology, forensics, and counter-bio terror applications. Additionally, PBIO is actively expanding the use of their pressure-based technologies in the following areas: (1) the use of their recently acquired technology from BaroFold, Inc. (the "Baro fold" technology) to allow entry into the biologics manufacturing and contract research services sector, and (2) the use of their recently-patented, scalable, high-efficiency, pressure-based Ultra Shear Technology ("UST") platform to (i) create stable nano emulsions of otherwise immiscible fluids (e.g., oils and water) and to (ii) prepare higher quality, homogenized, extended shelf-life or room temperature stable low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies.
Investment Highlights
Seasoned Management Team & Board of Directors
Annual Revenue of $2.24M (FY2017)
Three Novel, Enabling, Patent Protected, Proprietary Pressure-based Platforms
Proven Core Technology (Over 300 PCT Systems Installed): Razor/Razor blade Business Model
Sales into the Research Market (fast market penetration with minimal approvals required)
Increasing Number of 3rd Party Publications from Marquee Laboratories
PCT Breaks Through Bottlenecks and Barriers to Enable and Accelerate Scientific Discovery
PreEMT Can Impact and Improve Protein Drug Therapeutics
UST Offers the Potential to Produce Highly Stable Nano emulsions, Including in the Food and CBD Markets
Significant Multi-Billion Dollar Market Opportunity (~500K Scientists in 80K Labs Worldwide)
Company Overview
Three Business Segments - Three Unique Technology Platforms
Research Products and Services (PCT Platform)
PCT: Pressure Cycling Technology (alternating cycles of high/low pressure to control biomolecules)
Focus: to improve the quality of biological sample preparation, one of the most crucial yet errorprone steps in all of scientific research, performed by tens of thousands of scientists worldwide in pharma, biotech, academia and government research laboratories.
15 Patents, 300 PCT Systems installed, 175+ customers, 120+ publications, 2017 revenue ($2.24M)
Biological Contract Services (PreEMT Platform)
PreEMT: Pressure Enabled Protein Manufacturing Technology
Focus: to improve the quality of protein therapeutics, accelerate therapeutic protein development, and manufacture follow-on biologics by employing high pressure for dis aggregation & controlled refolding of re combinant proteins into their native structures for desired drug activity.
8 Patents, Dec 2017 BaroFold Acquisition, Initial Contract Underway, Negotiating with Client #2
Nanoemulsion Manufacturing Services (UST Platform)
UST: Ultra Shear Technology (combines high hydro static pressure & intense shear forces)
Focus: to produce higher quality, more stable nano emulsions with improved absorption, higher bio availability, and lower surfactant levels: food, pharmaceuticals, nutra ceuticals, cosmetics, lubricants, paint, and cannabis oil extracts (water soluble CBD) compared to standard emulsions
Short-Term Growth Drivers
Research Products & Services PCT Platform):
New Next Generation Barocycler 2320EXTREME
Additions to Sales & Marketing Team (one to four field sales managers in 2018)
Novel Micro-Pestle Consumable…Potential Use in Pathology, etc.
Four Additional PCT-based Instruments to be Released over Next 12 Months
PBI Products Fill Existing Needs in $291B (2021 est.) Bio pharmaceutical Market
Biological Contract Services (PreEMT Platform): Consistent Revenue Stream fromServices to Protein Therapeutic Companies…plus the Potential for Millions of dollars from Royalties on Manufacturing Scale Licenses
Nano emulsion Manufacturing Services (UST Platform): Consistent Revenue Stream from Services to Food, Cosmetic, and Nutraceutical (CBD, CBG) Markets for Potential Development of Low Cost, Scalable Production of Nano emulsions…plus the Potential for Millions of dollars from Royalties on Manufacturing Scale Licenses
Recent Developments for PBIO
Pressure Bio Sciences Makes CBD Oil Water Soluble, Offering Solution to CBD Absorption Issue in Food & Beverages
Last week, the Company released a short video demonstrating the Company's proprietary Ultra Shear Technology (USTTM) platform and its ability to create extremely small, nanometer-scale oil droplets that effectively dissolve in water (nano emulsions) to provide optimized bio availability for absorption.
New Video Demonstrates PBIO's Ultra Shear Technology and Potential Impact in CBD, Nutraceuticals, Foods, Cosmetics, and Other Oil-Based Markets
Last Wednesday, the Company released a short video demonstrating the their proprietary Ultra Shear Technology (USTTM) platform and its ability to create extremely small, nanometer-scale oil droplets that effectively dissolve in water (nanoemulsions) to provide optimized bio availability for absorption.
Dr. Bradford A. Young, Chief Commercial Officer of Pressure BioSciences, explained: ''We have all observed how oil and water do not normally mix or dissolve in each other, and routinely separate after mixing. Even with modern, advanced mixing technologies, oils remain in relatively large drops in water, which are poorly absorbed by the body. PBI's proprietary UST platform employs ultra-high pressure and extreme shearing forces to create very small, nano-scale emulsions (nanoemulsions) of oil droplets in water with vastly improved absorption and stability characteristics."
Bioavailability describes the percentage of and rate at which a substance is absorbed into the bloodstream. Oil-water emulsions of nutraceuticals and supplements present a serious challenge for many oral and transdermal therapies, due to most of the beneficial molecules remaining hidden inside of the oil drops. For CBD products commonly consumed orally - including CBD oils in edibles and beverages - absorption is typically below 10% (ERTH 8/28/2018: Water Soluble CBD - The Science of Nanoemulsion and Bioavailability). PBI believes that processing with the UST platform will deliver greatly improved absorption results (90% or higher) for CBD and other oil-based supplements.
Dr. Young continued: ''For many oil-based products, the ability to create nanoemulsions can improve a product's absorption, medicinal benefits, visual appearance, and sensory presentation. The potential for the UST platform to impact the CBD industry is promising, with the total cannabinoid market expected to hit $22 billion by 2022 (Brightfield Group, 2018), with CBD oil-based supplements being the cornerstone of this market. More importantly, while CBD is an attractive opportunity for our proprietary UST platform, we believe that the nutraceuticals, topicals and cosmetics, and food and beverage markets as mentioned could be 10-50 times larger. We will be addressing these additional market opportunities in parallel with our efforts in CBD.''
The short video released today is the first in a series of product-targeted video presentations designed to offer investors, future clients, and other interested groups additional information on PBI's UST platform and the numerous applications and opportunities for this transformational, proprietary technology.
The Company’s President and CEO, Mr. Richard T. Schumacher, recently joined Stock Day’s Mr. Everett Jolly to discuss the Company's most recent developments.
During the interview Mr. Schumacher discussed the following:
PBIO's recent collaboration With Nutra Fuels, Inc.,
The Commercial Launch of Their Bio Pharmaceuticals Contract Services Business.
The Publication of More Than Twenty Scientific Papers on the Company’s Unique Pressure-Based Products During 2018.
Please click here to listen to the full interview.
Technical Analysis:
As we stated before, PBIO appears to be a clear cut winner from a technical standpoint.
Regardless of its recent run-up, we still believe that PBIO has plenty of room to run from here.
The Company is still down thirty-nine percent from its 52-week high of $5.00.
A run back to that high would show traders over +63% in pure profit from today's alert price.
Let's also not forget that the float for PBIO is ridiculously thin at just 1.65 M.
With a float that tight, PBIO has the potential to break out for significant gains in a very short amount of time.
We already witnessed this just a few days ago, when shares of PBIO shot up over +51% in just one session.
We ask that you read up on all of PBIO's most recent news here, and add it to the top of your watch list!
Best Regards,
The TopMarket.Gainers Team
Don't Miss Our Next Huge Winner...
Text 'GAINS' to '67076'
to have our Trade Alerts
Delivered Direct
to your Cell Phone.
(There is no charge.
Msg&data rates may apply.)
DISCLAIMER
This newsletter is a paid advertisement, not a recommendation nor an offer to buy or sell securities. This newsletter is owned, operated and edited by both MJ Capital, LLC and PennyStockLocks, LLC. Any wording found in this e-mail or disclaimer referencing to “I” or “we” or “our” refers to MJ Capital, LLC and PennyStoc.kLocks, LLC. Our business model is to be financially compensated to market and promote small public companies. By reading our newsletter and our website you agree to the terms of our disclaimer, which are subject to change at any time. We are not registered or licensed in any jurisdiction whatsoever to provide investing advice or anything of an advisory or consultancy nature, and are therefore are unqualified to give investment recommendations. Always do your own research and consult with a licensed investment professional before investing. This communication is never to be used as the basis of making investment decisions, and is for entertainment purposes only. At most, this communication should serve only as a starting point to do your own research and consult with a licensed professional regarding the companies profiled and discussed. Conduct your own research. Companies with low price per share are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold our site, its editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters or on our website.
We do not advise any reader take any specific action. Losses can be larger than expected if the company experiences any problems with liquidity or wide spreads. Our website and newsletter are for entertainment purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter and on our website may be based on end-of-day or intra.day data. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. If we own any shares we will list the information relevant to the stock and number of shares here. MJ Capital does NOT own any shares of the companies mentioned here.within, nor intends to buy any in the future.
MJ Capital’s business model is to receive financial compensation to promote public companies. We have been compensated ten thousand dollars by the Financial Marketing Group to conduct investor relations advertising and marketing for PBIO. We have previously been compensated ten thousand dollars by the Financial Marketing Group to conduct investor relations advertising and marketing for PBIO -which has expired. Any compensation is a major conflict of interest in our ability to be unbiased. Therefore, this communication should be viewed as a commercial advertisement only. We have not investigated the background of the hiring third party or parties. The third party, profiled company, or their affiliates likely wish to liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices. Any non-compensated alerts are purely for the purpose of expanding our database for the benefit of our future financially compensated investor relations efforts. Frequently companies profiled in our alerts may experience a large increase in volume and share price during the course of investor relations marketing, which may end as soon as the investor relations marketing ceases. The investor relations marketing may be as brief as one day, after which a large decrease in volume and share price is likely to occur. Our emails may contain forward looking statements, which are not guaranteed to materialize due to a variety of factors.
We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters and on our website is believed to be accurate and correct, but has not been independently verified and is not guaranteed to be correct. The information is collected from public sources, such as the profiled company’s website and press releases, but is not researched or verified in any way whatsoever to ensure the publicly available information is correct. Furthermore, MJ Capital often employs independent contractor writers who may make errors when researching information and preparing these communications regarding profiled companies. Independent writers’ works are double-checked and verified before publication, but it is certainly possible for errors or omissions to take place during editing of independent contractor writer’s communications regarding the profiled company(s). You should assume all information in all of our communications is incorrect until you personally verify the information, and again are encouraged to never invest based on the information contained in our written communications. The information in our disclaimers is subject to change at any time without notice.
$KO | #CocaCola looks like a BUY here! Sitting on MAJOR SUPPORT!$KO | #CocaCola looks like a BUY here! Sitting on MAJOR SUPPORT!
$PBIO has a Perfect Chart w/ Millions in Revenue, Low Float &...$PBIO has a Perfect Chart w/ Millions in Revenue, Low Float & Insider Buying:
=====================
PBIO (Pressure BioSciences Inc.)
Current Price: $2.19
Float: 1.65M
Chart Analysis
Investor Presentation
========================
Members,
We hope you enjoyed the up to +56% in intraday gains that today's trade idea provided.
If you liked today's trade action, you are going to love what we have in store for you next.
Please turn your immediate attention to PBIO (Pressure BioSciences Inc.).
Just like our most recent winner, this leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences industry, trades on the OTCQB, and has tight float of less than 2M.
PBIO traded nicely today, closing the session up nearly three percent.
We feel confident that this bullish momentum will continue onto tomorrow, as it appears that an uptrend is beginning to take shape.
PBIO has also been getting plenty of positive press as of late.
The Company’s President and CEO, Mr. Richard T. Schumacher, recently joined Stock Day’s Mr. Everett Jolly to discuss the Company's recent successes.
During the interview Mr. Schumacher discussed PBIO's most recent achievements, all of which could be considered bullish catalysts in the immediate future:
Their recent collaboration With NutraFuels, Inc.,
The Commercial Launch of Their BioPharmaceuticals Contract Services Business.
The Publication of More Than Twenty Scientific Papers on the Company’s Unique Pressure-Based Products During 2018.
On top of this, we also noticed some insider buying from PBIO's management in late December.
This leads us to believe that PBIO's management considers the Company's stock price to be undervalued at the moment.
PBIO also looks like a clear cut winner from a technical standpoint as well.
We've done our own chart analysis, and we have to admit, we haven't seen a chart this pretty in quite some time.
This appears to be a bottom-chart play, sitting on a golden pocket, with the potential to more than double in price.
It looks like we have another big mover on our hands here with PBIO.
That being said, we are urging all members to read our full profile, start their research now, and consider grabbing up a position in PBIO tomorrow morning at 9:30AM EST!
About Pressure BioSciences, Inc.
Pressure BioSciences, Inc. (PBIO) is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences industry. Their products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or "PCT") hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions (e.g., cell lysis, biomolecule extraction). Their primary focus is in the development of high pressure-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, food science, soil & plant biology, forensics, and counter-bioterror applications. Additionally, PBIO is actively expanding the use of their pressure-based technologies in the following areas: (1) the use of their recently acquired technology from BaroFold, Inc. (the "Barofold" technology) to allow entry into the biologics manufacturing and contract research services sector, and (2) the use of their recently-patented, scalable, high-efficiency, pressure-based Ultra Shear Technology ("UST") platform to (i) create stable nanoemulsions of otherwise immiscible fluids (e.g., oils and water) and to (ii) prepare higher quality, homogenized, extended shelf-life or room temperature stable low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies.
Investment Highlights
Seasoned Management Team & Board of Directors
Annual Revenue of $2.24M (FY2017)
Three Novel, Enabling, Patent Protected, Proprietary Pressure-based Platforms
Proven Core Technology (Over 300 PCT Systems Installed): Razor/Razorblade Business Model
Sales into the Research Market (fast market penetration with minimal approvals required)
Increasing Number of 3rd Party Publications from Marquee Laboratories
PCT Breaks Through Bottlenecks and Barriers to Enable and Accelerate Scientific Discovery
PreEMT Can Impact and Improve Protein Drug Therapeutics
UST Offers the Potential to Produce Highly Stable Nanoemulsions, Including in the Food and CBD Markets
Significant Multi-Billion Dollar Market Opportunity (~500K Scientists in 80K Labs Worldwide)
Company Overview
Three Business Segments - Three Unique Technology Platforms
Research Products and Services (PCT Platform)
PCT: Pressure Cycling Technology (alternating cycles of high/low pressure to control biomolecules)
Focus: to improve the quality of biological sample preparation, one of the most crucial yet errorprone steps in all of scientific research, performed by tens of thousands of scientists worldwide in pharma, biotech, academia and government research laboratories.
15 Patents, 300 PCT Systems installed, 175+ customers, 120+ publications, 2017 revenue ($2.24M)
Biological Contract Services (PreEMT Platform)
PreEMT: Pressure Enabled Protein Manufacturing Technology
Focus: to improve the quality of protein therapeutics, accelerate therapeutic protein development, and manufacture follow-on biologics by employing high pressure for disaggregation & controlled refolding of recombinant proteins into their native structures for desired drug activity.
8 Patents, Dec 2017 BaroFold Acquisition, Initial Contract Underway, Negotiating with Client #2
Nanoemulsion Manufacturing Services (UST Platform)
UST: Ultra Shear Technology (combines high hydrostatic pressure & intense shear forces)
Focus: to produce higher quality, more stable nanoemulsions with improved absorption, higher bioavailability, and lower surfactant levels: food, pharmaceuticals, nutraceuticals, cosmetics, lubricants, paint, and cannabis oil extracts (water soluble CBD) compared to standard emulsions
Short-Term Growth Drivers
Research Products & Services PCT Platform):
New Next Generation Barocycler 2320EXTREME
Additions to Sales & Marketing Team (one to four field sales managers in 2018)
Novel Micro-Pestle Consumable…Potential Use in Pathology, etc.
Four Additional PCT-based Instruments to be Released over Next 12 Months
PBI Products Fill Existing Needs in $291B (2021 est.) Biopharmaceutical Market
Biological Contract Services (PreEMT Platform): Consistent Revenue Stream fromServices to Protein Therapeutic Companies…plus the Potential for Millions of dollars from Royalties on Manufacturing Scale Licenses
Nanoemulsion Manufacturing Services (UST Platform): Consistent Revenue Stream from Services to Food, Cosmetic, and Nutraceutical (CBD, CBG) Markets for Potential Development of Low Cost, Scalable Production of Nanoemulsions…plus the Potential for Millions of dollars from Royalties on Manufacturing Scale Licenses
Recent Developments
In late January PBIO announced news of a collaboration with NutraFuels Inc., to advance the development of a new generation of health and wellness nutraceutical products based on processing by PBI's proprietary Ultra Shear Technology (UST™) platform. The Companies believe that nanoemulsions prepared by the UST Platform will have improved quality and effectiveness compared to current emulsions, which will help to facilitate the development of a new generation of improved nutraceutical and other emulsion-based products, such as cosmetics.
Edgar J. Ward, President and CEO of NTFU, said: "We pride ourselves in ensuring that we incorporate the highest level of quality possible in our manufactured products. When we heard that PBI was developing their new, proprietary UST processing platform, and learned of its potential to significantly increase the quality and effectiveness of nutraceutical products, we spoke with PBI and offered to help accelerate its commercial introduction. We are thrilled to be working with such experienced scientific leaders and innovators, in a program that we believe can change lives worldwide for the better."
Mr. Ward continued: "We believe PBI's UST platform has the potential to create long-term room temperature stable, water-soluble nanoemulsions of oil-based solutions. Nanoemulsions are known to offer greater stability and bioavailability than the standard macroemulsions used today in nutraceuticals, cosmetics, and other industries. We are excited to have the opportunity to work with a life science industry leader in the optimization of a process that has the potential to bring higher quality not just to our products, but to nutraceutical products worldwide."
Dr. Bradford A. Young, Chief Commercial Officer of PBI, commented: "We are pleased to have the opportunity to work with NTFU's scientists and manufacturing personnel in the development of new and improved nutraceutical products utilizing our UST platform. This proprietary technology employs ultra-high pressure and extreme shearing forces to create nano-scale emulsions of oil and water with long-term stability. For many oil-based products, the ability to create very small, nanometer-sized oil droplets that can effectively dissolve in water (nanoemulsions) can improve a product's appearance, sensory and medicinal benefits. There is a large and growing market opportunity for nutraceutical products with proven health and wellness benefits. We believe PBI's UST platform can help manufacturers accelerate growth and success in this market with higher quality, water-soluble, oil-based products with superior dietary absorption and shelf-life."
Mr. Richard T. Schumacher, President and CEO of PBI, added: "We are excited to work with Edgar and his NTFU team in the optimization of our UST platform, which we believe will result in the development of new and beneficial health and wellness products. The staff at NTFU has years of experience in manufacturing nutraceutical products in a quality environment. They also have access to both raw materials and finished goods, both of which are needed for optimization. Finally, they have an existing analytical laboratory with state-of-the-art equipment and well-trained chemists who can perform testing on both pre and post-processed materials, which will be invaluable to the optimization process. This collaboration clearly supports both company's strategic objectives: we look forward to an exciting and mutually beneficial relationship with our colleagues at NutraFuels."
Last month, PBIO announced the commercial launch of its Biopharmaceuticals Contract Services Business. The launch of this new business has been eagerly anticipated following the Company's acquisition of the assets of BaroFold, Inc. in December 2017, including patents, equipment, and other intellectual property relating to Barofold's unique, high pressure-based protein disaggregation and refolding platform.
PBI expects that the unique Barofold technology platform will substantially improve the quality and costs of manufacturing protein therapeutics, by helping to resolve protein aggregation, improving solubility, and refolding complex misfolded protein therapeutic molecules into their desired, therapeutically-optimized conformations for improved drug efficacy and lower immunogenicity.
Protein-based therapeutic drugs are a large and rapidly growing part of the global healthcare industry. There are over 200 therapeutic proteins and peptides approved for clinical use in the U.S. (THPdb database: crdd.osdd.net). Protein therapeutics are valued for their more potent and specific therapeutic effectiveness for many diseases, such as cancer and auto-immune disorders. They are also the preferred treatment choices for hormone and growth factor deficiencies. Research and Markets (May 2016) forecasted that the global protein drug market will grow to $248 billion by 2020.
Market Outlook
Proprietary Technology Platform Offers Improved Manufacturing for Protein Therapeutic Candidates and Positions PBIO to Service the $250 Billion Global Biopharmaceuticals Market
The United States remains the largest medical device market in the world, with a market size of around $156 billion, and it represented about 40 percent of the global medical device market in 2017. U.S. exports of medical devices in key product categories identified by the Department of Commerce (DOC) exceeded $41 billion in that year. The medical technology industry (commonly referred to as medical devices) consists of articles, instruments, apparatuses, or machines that are used in the prevention, diagnosis or treatment of illness or disease, or for detecting, measuring, restoring, correcting, or modifying the structure or function of the body for some health purpose. Typically, the purpose of a medical device is not achieved by pharmacological, immunological, or metabolic means.
The industry is responsible for almost 2 million jobs in the United States, including both direct and indirect employment. Medical technology directly accounts for well over 500,000 of these jobs. More than 80 percent of medical device companies in the United States consist of fewer than 50 employees, and many (notably start-up companies) have little or no sales revenue. The medical technology industry employs people in all 50 states. U.S. medical device companies are highly regarded globally for their innovative and high technology products. R&D spending continues to represent a high percentage of medical device industry expenditures, averaging 7 percent of revenue. Compared to several other industries including automotive, defense, and telecommunications, the medical device industry invests a higher percentage of yearly revenues into product innovation, reflecting the competitive nature of the industry and constant innovation and improvement of existing technologies.
The medical device industry relies on several industries where the United States holds a competitive advantage, including microelectronics, telecommunications, instrumentation, biotechnology, and software development. Collaborations have led to recent advances including neuro-stimulators, stent technologies, biomarkers, robotic assistance, and implantable electronic devices. Since innovation fuels the medical device sector’s ongoing quest for better ways to treat and diagnose medical conditions, when coupled with patient life expectancy increasing and aging populations globally, the medical device sector should continue growing at a positive rate in the future.
Technical Analysis
AS we stated above, PBIO appears to be a clear cut winner from a technical standpoint as well.
We've done our own chart analysis, and we have to admit, we haven't seen a chart this pretty in quite some time.
This appears to be a bottom-chart play, sitting on a golden pocket, with the potential to more than double in price.
PBIO has plenty of room to run from here.
The Company is currently down fifty-six percent from its 52-week high of $5.00.
A run back to that high would show traders over +128% in pure profit from today's alert price.
Let's also not forget that the float for PBIO is ridiculously thin at just 1.65M.
With a float that tight, PBIO has the potential to break out for significant gains should it see a sudden burst in trade volume.
If any market friendly news were to be released, we could see shares of PBIO sky-rocket!
We are urging all members to start their research now, and consider grabbing up a position in PBIO tomorrow morning at 9:30AM EST!
(*Remember to use a Stop-Loss Order or basic Limit Order to protect your gains, as well as limit possible losses.)
Best Regards,
The TopMarketGainers Team
Don't Miss Our Next Huge Winner...
Text 'GAINS' to '67076'
to have our Trade Alerts
Delivered Direct
to your Cell Phone.
(There is no charge.
Msg&data rates may apply.)
DISCLAIMER
This newsletter is a paid advertisement, not a recommendation nor an offer to buy or sell securities. This newsletter is owned, operated and edited by both MJ Capital, LLC and PennyStockLocks, LLC. Any wording found in this e-mail or disclaimer referencing to “I” or “we” or “our” refers to MJ Capital, LLC and PennyStockLocks, LLC. Our business model is to be financially compensated to market and promote small public companies. By reading our newsletter and our website you agree to the terms of our disclaimer, which are subject to change at any time. We are not registered or licensed in any jurisdiction whatsoever to provide investing advice or anything of an advisory or consultancy nature, and are therefore are unqualified to give investment recommendations. Always do your own research and consult with a licensed investment professional before investing. This communication is never to be used as the basis of making investment decisions, and is for entertainment purposes only. At most, this communication should serve only as a starting point to do your own research and consult with a licensed professional regarding the companies profiled and discussed. Conduct your own research. Companies with low price per share are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold our site, its editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters or on our website.
We do not advise any reader take any specific action. Losses can be larger than expected if the company experiences any problems with liquidity or wide spreads. Our website and newsletter are for entertainment purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter and on our website may be based on end-of-day or intraday data. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. If we own any shares we will list the information relevant to the stock and number of shares here. MJ Capital does NOT own any shares of the companies mentioned herewithin, nor intends to buy any in the future.
MJ Capital’s business model is to receive financial compensation to promote public companies. We have been compensated ten thousand dollars by the Financial Marketing Group to conduct investor relations advertising and marketing for PBIO. Any compensation is a major conflict of interest in our ability to be unbiased. Therefore, this communication should be viewed as a commercial advertisement only. We have not investigated the background of the hiring third party or parties. The third party, profiled company, or their affiliates likely wish to liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices. Any non-compensated alerts are purely for the purpose of expanding our database for the benefit of our future financially compensated investor relations efforts. Frequently companies profiled in our alerts may experience a large increase in volume and share price during the course of investor relations marketing, which may end as soon as the investor relations marketing ceases. The investor relations marketing may be as brief as one day, after which a large decrease in volume and share price is likely to occur. Our emails may contain forward looking statements, which are not guaranteed to materialize due to a variety of factors.
We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters and on our website is believed to be accurate and correct, but has not been independently verified and is not guaranteed to be correct. The information is collected from public sources, such as the profiled company’s website and press releases, but is not researched or verified in any way whatsoever to ensure the publicly available information is correct. Furthermore, MJ Capital often employs independent contractor writers who may make errors when researching information and preparing these communications regarding profiled companies. Independent writers’ works are double-checked and verified before publication, but it is certainly possible for errors or omissions to take place during editing of independent contractor writer’s communications regarding the profiled company(s). You should assume all information in all of our communications is incorrect until you personally verify the information, and again are encouraged to never invest based on the information contained in our written communications. The information in our disclaimers is subject to change at any time without notice.
Silver is a Screaming BuyAll long-looking indicators point to silver being undervalued vs gold. Top chart shows silver candlesticks vs gold red line as percentage returns since 1998. Middle indicator is the Trader's Dynamic Index (TDI) which holds a combination of moving average, volatility and momentum trends. Bottom indicator is the infamous Gold:Silver ratio.
Silver is sitting on top of the .382 fib level support shown in the chart, which is where the current cost of production resides around $14.75/oz. Low risk, high reward - this is a perfect setup for those interested in making an inflation play going toward negative rates, QE4 and the end of the petrodollar.
% Returns Analysis: Silver below Gold -> Silver undervalued
Fibonacci Level: Strong support at cost of production near $14.75/oz
TDI: Bullish divergence in formation
Gold/Silver ratio: 83:1 -> Silver undervalued
#BitcoinSV | $BSV/btc is currently sitting in the GOLDEN POCKET!#BitcoinSV | $BSV/btc is currently sitting in the GOLDEN POCKET! Taking a chance. Will definitely add a stop-loss soon; in case of pattern invalidation!
$CMPY: This past +30% winner just signed a deal w/ Tech Giant...=====================
CMPY (Comepay Inc.)
Alert Price: $4.30
Float: 476.342K
Chart Analysis
========================
Members,
It's only Tuesday, and our trade ideas have already delivered as much as +187% in long-term profit!
For our next trade idea, we are revisiting one of our biggest winners of Q1 2019.
Please turn your immediate attention to CMPY (Comepay Inc.).
The last time we brought CMPY to your attention, shares of this up-and-coming payment solutions provider rallied over +31% from $4.00 to a high of $5.25!
Shares of CMPY have since pulled back to a much more attractive entry price of $4.30, but we believe its next run past $5.00 could start as early as tomorrow.
Here's why...
CMPY has recently added tech industry giant Asus to its already impressive client list, which includes automotive giant Volvo, and industrial juggernaut Bosch.
It's not often you see multi-billion dollar market cap companies sign contracts with little known companies like CMPY.
This leads us to believe that CMPY's technology is best in breed, and that the Company itself is undervalued at the moment!
It's no surprise that CMPY's management plans to uplist the Company this year,
If you didn't know already, CMPY operates in one of the most lucrative sectors on Wall St., with companies like Square Inc. delivering over +175% in returns within the last year.
Currently trading at $4.30 per share, we believe that CMPY shows traders much more upside potential than the bigger names in this sector.
This has the potential to be one of our biggest winners of Q1 2019.
If you missed out on CMPY's previous +31% run, you may want to consider jumping on board this time around.
That being said, we are urging all members to read our full profile, start their research now, and consider grabbing up a position in CMPY tomorrow morning at 9:30AM EST!
About Comepay
The Comepay group of companies including Comepay, RP Systems, M-NN LLC and Chek-online have been operating for over 11 years providing internet acquiring services and support, facilitating instant payments and internet-based payment transactions via kiosks, mobile interfaces and web-based applications such as electronic wallets. The Company also leases and sells cash registers and Point of Sale (POS) systems, including its recently developed proprietary multifunctional smart POS fiscal cash register system. Combining proprietary software and equipment, Comepay processes over 10 million customer payments per month and presently has more than 22,000 kiosks across Russia. The companies are currently focusing their planned business expansion on the smart POS fiscal cash register system called “Cassatka” in order to help businesses comply with newly released Russian taxation legislation, 54-FZ which requires 1.2 million businesses in fiscal 2018, and a further 1.4 million businesses in fiscal 2019 to install new, federally compliant on-line cash registers. The Cassatka, Comepay’s multifunctional smart POS online fiscal cash register can process payments and meet fiscal data storage requirements for participating businesses. It is a convenient and cost competitive solution for businesses to meet the new federal taxation requirements in Russia, and is currently being manufactured for distribution prior to June 2018. As the companies expand their business model, we expect to offer blockchain acquiring services and also to accept payments in multiple crypto currencies on the Cassatka. The Comepay group of companies presently earn revenue from a variety of channels including fee based commissions on payment processing for both cash and debit card payments, software licensing, kiosk placement fees and other rental fees for cash registers and associated equipment. The Comepay companies are looking to expand rapidly in fiscal 2018 and beyond as we introduce and market the Cassatka along with a suite of enhanced user features. Please see websites below: www.comepaygroup.com, www.comepay.ru, www.Cassatka.me, www.chekonline.ru, www.starrys.ru
Bullish Catalysts for CMPY
Added Asus as its newest customer in order to bring their online store compliant with Russian Federal Law 54, requiring businesses and individuals to use federally compliant cash registers, including a fiscal chip for processing sales transactions.
CMPY has been one of the market's top performing publicly trading companies, with shares up over 1,333% over the last 52-weeks!
Based on our very own chart analysis, we see the realistic potential for a +128% move.
Processes over 10 million customer payments per month and presently has more than 22,000 kiosks across Russia.
Added increased functionality to its smart terminals including the Unified State Automated Information System (“USAIS”) app, in order to simplify reporting of alcoholic beverages and products to the Federal Tax Authority of the Russian Federation, including the ability to issue industry compliant receipts for alcoholic products sold.
Upcoming release of a full-featured version of its app for iOS- and Android-based smartphones and tablets. Chek-online development staff are yet to disclose the name of the app and its exact release date, but expect the app to be launched no later than May of 2019.
Recently signed up Volvo (Russia) for provision of stationary smart terminal units located inside its data centers in Russia.
Entered into a lease agreement with Bosch, a global market leader in electronics and engineering, for provision of stationary smart terminal units located inside its data centers in Russia.
Upcoming release of a full-featured version of its app for iOS- and Android-based smartphones and tablets.
Partnership with Russian retail bank, Post Bank, for purchase and sale of the Cassatka, their fully compliant smart terminal cash register line to meet fiscal compliance legislation across Russia.
The Company has plans to uplist this year.
5 Reasons Why We Think CMPY Needs to be on Top of Your Watchlist
THE RIGHT SPACE
How are tech stocks in the market looking? Wall Street will tell you it’s the hottest investment market in a decade. It’s on fire, literally and figuratively.
INNOVATIVE PRODUCTS
CMPY is all about the payments.CMPY uses tech to make payments easier and more efficient. We believe this provides investors a unique opportunity to acquire an interest in an upcoming tech company that could be a leader in the payment industry.
UNDER THE RADAR
Being new to the market and hovering under the radar of Wall Street, we believe CMPY is attractive in comparison to its peers. And up until now, one of the best-kept secrets.
MASSIVE GROWTH POTENTIAL
The market opportunity for CMPY is HUGE! Comepay could take the mobile payment markets by storm.
THE BEST AND THE BRIGHTEST
Boasting a “top-tier technology that is unmatched in the industry”, the CMPY provides a one-stop source for everything payment related.
Recent Developments
IS CMPY GOING TO REVOLUTIONIZE ONLINE PAYMENTS?
Comepay, Inc. (CMPY) (“the Company”) is pleased to announce that its wholly owned subsidiary Chek-Online LLC, a leading manufacturer of fiscal cash registers in Russia, and developer of the family of Cassatka smart terminals has disclosed the upcoming release of a full-featured version of its app for iOS- and Android-based smartphones and tablets. Chek-online development staff are yet to disclose the name of the app and its exact release date, but expect the app to be launched no later than May of 2019.
The mobile app is designed to allow all users who have downloaded the platform to easily find outlets that use the Cassatka online cash terminal: view all available products, compare prices, receive discounts and immediately place orders for delivery to any location in the city, paying remotely using their bankcard.
The seller, in turn, will receive a notification about the online order on their Cassatka smart terminal, and will be able to process the order for delivery.
The details of the products featured on the app will be made available using the built-in accounting system provided with the fiscal cash register. Business owners can update their back end system in order for the app to provide details such as products for sale, number of units in stock, price and available discounts. All information provided in the app is automatically synchronized with the individual login account for the business owner and transferred to the app. Data transferred to the app is available for download by any interested consumer.
Currently, more than 20,000 individual businesses across Russia are selling their products and processing payments using our series of Cassatka online cash registers, with new users being added on a daily basis.
According to the Chek-online development team, this app is intended to establish a direct connection between the seller and the buyer, creating a comfortable environment for online. The app is also intended to drive potential customers to mobile storefronts and encourage online trade.
It was important to the Chek-online development team that users can compare both like products from storefronts in the same product category, as well as other product categories. As a result, potential customers are able to create a multi-category basket in the app pulling product from different stores into one easy to use comparison and purchase process. The app is designed to provide all the advantages and benefits that come with other online shopping providers. Customers will easily be able to access the necessary information about the products in order to quickly and efficiently be able to make an informed decision about online purchases.
Market Outlook
Global payments revenues swelled to $1.9 trillion in 2017, the best single year of growth in the last five years.
The Asia–Pacific region, including China—which currently accounts for the largest share of payments revenues (40 percent)—will continue to be the engine of growth. It will comprise 56 percent of the global increase in revenues during the next five years, with China alone accounting for 40 percent of the global increase. However, Western Europe and developed Asia, where growth rates have been negative in recent years, will also rebound. Cross-border payments and trade finance will benefit in the coming years as well, driven by the strong recovery expected in trade flows (which have a projected compound annual growth rate of 8 percent from 2013 to 2018).
This return to strong growth is being fueled primarily by sustainable volume increases, rather than less sustainable improvements in revenue margins, for both liquidity revenues (net interest income on liquid assets and deposits2 ) and transactional revenues (fee and float income on payments transactions). Indeed, margin improvement will barely contribute to the $410 billion increase in liquidity revenues between 2013 and 2018. Transactional revenues will increase by $340 billion by 2018 due to higher transaction volumes, despite the dampening effects of more regulation and competition.
Technical Analysis
We love alerting these past winners because we already have a good idea of their trading behavior.
From what we see right now, CMPY appears to be primed and ready to break through its $5.00 resistance.
Based on our very own chart analysis, we see the realistic potential for a +128% move.
With its low-float of 476,342K, CMPY appears to move on air!
On December 27th, we saw its share price nearly double on light volume!
We've already watched CMPY tick up over +31% in just a few days time.
If you missed out on CMPY's previous +31% run, you may want to consider jumping on board this time around.
This has the potential to be one of our biggest winners of Q1 2019!
As such, we are urging all members to start their research now, and consider grabbing up a position in CMPY tomorrow morning at 9:30AM EST!
(*Remember to use a Stop-Loss Order or basic Limit Order to protect your gains, as well as limit possible losses.)
Best Regards,
The TopMarketGainers Team
Don't Miss Our Next Huge Winner...
Text 'GAINS' to '67076'
to have our Trade Alerts
Delivered Direct
to your Cell Phone.
(There is no charge.
Msg&data rates may apply.)
DISCLAIMER
This newsletter is a paid advertisement, not a recommendation nor an offer to buy or sell securities. This newsletter is owned, operated and edited by both MJ Capital, LLC and PennyStockLocks, LLC. Any wording found in this e-mail or disclaimer referencing to “I” or “we” or “our” refers to MJ Capital, LLC and PennyStockLocks, LLC. Our business model is to be financially compensated to market and promote small public companies. By reading our newsletter and our website you agree to the terms of our disclaimer, which are subject to change at any time. We are not registered or licensed in any jurisdiction whatsoever to provide investing advice or anything of an advisory or consultancy nature, and are therefore are unqualified to give investment recommendations. Always do your own research and consult with a licensed investment professional before investing. This communication is never to be used as the basis of making investment decisions, and is for entertainment purposes only. At most, this communication should serve only as a starting point to do your own research and consult with a licensed professional regarding the companies profiled and discussed. Conduct your own research. Companies with low price per share are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold our site, its editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters or on our website.
We do not advise any reader take any specific action. Losses can be larger than expected if the company experiences any problems with liquidity or wide spreads. Our website and newsletter are for entertainment purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter and on our website may be based on end-of-day or intraday data. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. If we own any shares we will list the information relevant to the stock and number of shares here. MJ Capital does NOT own any shares of the companies mentioned herewithin, nor intends to buy any in the future
MJ Capital’s business model is to receive financial compensation to promote public companies. We have been compensated twelve thousand five hunded dollars by Awareness Consulting Network to conduct investor relations advertising and marketing for CMPY. We have been previously compensated ten thousand dollars by Awareness Consulting Network to conduct investor relations advertising and marketing for CMPY- which has expired. Any compensation is a major conflict of interest in our ability to be unbiased. Therefore, this communication should be viewed as a commercial advertisement only. We have not investigated the background of the hiring third party or parties. The third party, profiled company, or their affiliates likely wish to liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices. Any non-compensated alerts are purely for the purpose of expanding our database for the benefit of our future financially compensated investor relations efforts. Frequently companies profiled in our alerts may experience a large increase in volume and share price during the course of investor relations marketing, which may end as soon as the investor relations marketing ceases. The investor relations marketing may be as brief as one day, after which a large decrease in volume and share price is likely to occur. Our emails may contain forward looking statements, which are not guaranteed to materialize due to a variety of factors.
We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters and on our website is believed to be accurate and correct, but has not been independently verified and is not guaranteed to be correct. The information is collected from public sources, such as the profiled company’s website and press releases, but is not researched or verified in any way whatsoever to ensure the publicly available information is correct. Furthermore, MJ Capital often employs independent contractor writers who may make errors when researching information and preparing these communications regarding profiled companies. Independent writers’ works are double-checked and verified before publication, but it is certainly possible for errors or omissions to take place during editing of independent contractor writer’s communications regarding the profiled company(s). You should assume all information in all of our communications is incorrect until you personally verify the information, and again are encouraged to never invest based on the information contained in our written communications. The information in our disclaimers is subject to change at any time without notice.
NWGFF is our new cannabis breakout pick. See why a +60pct move..=====================
NWGFF New Age Brands Inc.
Alert Price: $0.0478
Chart Analysis
========================
Members,
Are you ready to kickoff the month of February with a bang?
For our next trade idea, we are focusing on a red-hot sector that has proven highly profitable for our members time and time again.
That's right, it's time for another cannabis play...
Please turn your full attention to NWGFF (New Age Brands Inc.).
After witnessing a downtrend the past few months, NWGFF appears to have finally bottom'd out.
NWGFF has been quietly building up momentum, and is now showing signs of a highly profitable bullish reversal in the making
Shares of NWGFF closed up over +17% today, while trading on higher than average volume, and we are feeling confident that another double-digit move is in store for NWGFF tomorrow.
There's a strong change that today's double-digit move caught the Street's attention, so don't be surprised if we see a move past $0.05 early tomorrow!
If you look at NWGFF's 1-year chart, you will see that the last time we saw this particular setup, shares rallied +200% from $0.04 all the way to $0.12!
NWGFF appears to be grossly oversold and undervalued at these levels, especially when you take into account the growth initiatives their management has made over the past few months.
The Company has made several market friendly announcements as of late, all of which could be considered bullish catalysts as we head into Q1 2019.
MassRoots, Inc. a leading technology and rewards platform, signed an agreement with NWGFF subsidiary, We are Kured, LLC, to serve as a leading online retailer of the Company's #1 best-selling CBD Pen.*
Wholly owned subsidiary, We Are Kured, LLC (“Kured”), plans to launch a new vape option for their broad spectrum 48% CBD oil. Although their main product offering will be the current 500mg disposable vaporizing pen, this new vaporizing cartridge will help round out KURED’s product line.
We Are Kured, LLC’s Pineapple Express vape pen is the top selling vape pen at the iconic Native Roots Wellness CBD store in Denver, Colorado. The success of the vape product in the leading CBD market in Denver, one of the most advanced in the country, is helping to increase awareness of both the Company and the benefits of the new and burgeoning CBD market for consumers and investors.
Entered into a “Drop Ship” agreement with The Grown Depot with respect to their two fully owned subsidiaries, We Are Kured, LLC and Drink Fresh Water LLC. Under the terms of the agreement, The Grown Depot will sell the Company’s products through their website (www.TheGrownDepot.com) while the Company will facilitate the shipment of orders through their Denver, Colorado warehouse.
Secured an order of its wholly owned subsidiary’s Fresh Water CBD product with Colorado’s largest liquor store, Argonaut Liquors, located on Colfax in downtown Denver. Argonaut Liquors, a historical Denver staple liquor store, is seeing the momentum of CBD water and wants to be ahead of the competition by offering Fresh Water CBD to their 21+ clientele.
As you can see, the management at NWGFF is taking a highly aggressive approach in increasing brand awareness.
The Company's CBD Pen is a hit already, and its only a matter of time until we see its effect on NWGFF's bottom line.
In addition to having a top selling product, NWGFF is also very attractive from a technical standpoint.
Based on our very own chart analysis, we see the potential for a move of +60%!
We know it has already been a highly profitable week/month for our members, but we believe NWGFF could add a significant amount to that already impressive gains total.
That being said, we ask that all members read our full profile, start their research now, and consider grabbing up a position in NWGFF tomorrow morning at 9:30AM EST!
About New Age Brands Inc.
New Age Brands is an innovative Cannabidiol ("CBD") lifestyle Company. Through the Company's wholly owned subsidiaries We are Kured and Drink Fresh Water, the Company's main business activities encompass the development, marketing and distribution of CBD products (including vaporizer pens and beverages) throughout the United States and internationally. In addition, New Age Brands has extensive retail and cultivation land investments in Oregon.
About We Are Kured, LLC
KURED is a wholly owned subsidiary of New Age Brands, acquired in December 2017. KURED is building an innovative online CBD and lifestyle company. KURED has partnered with best in class hemp cultivators, edible manufacturers, cutting edge product formulators to develop, market and distribute multiple lines of CBD products including, but not limited to, CBD vaporizer pens, topicals, gel capsules and more. All of We Are Kured's products are 100% THC free and will be available for purchase internationally. THC, or tetrahydrocannabinol, is the primary active ingredient in cannabis.
NWGFF is growing quickly in the Cannabis industry, and it's doing so by focusing on the fundamentals. The Denver-based company is meticulously carving out its share of the emerging hemp and CBD markets in the U.S., Canada and South America. And, in the process, it's providing the cannabis space with more choices while offering investors an opportunity to get in on the ground floor of an ever-expanding company.
First and foremost, to understand more about New Age Brands , we have to understand the markets within the cannabis industry that they've chosen to call home—the Hemp and CBD markets. Hemp is the fiber and seed part, and the most valuable part of the Cannabis plant, which is why hemp is often called a "cash crop."
Meanwhile, CBD or cannabidiol is a naturally occurring cannabinoid in hemp that has significant medicinal benefits without the psychoactivity of THC. CBD is an appealing option for patients looking for relief from inflammation, pain, anxiety, psychosis, seizures, spasms, and a host of other conditions.
So how has New Age Brand's management chosen to create what it feels will be a successful footprint in the cannabis industry?
Well, while many smaller companies use lots of press releases and promises of great things to come to attract investors, executives at New Age Brands are actually building the company fundamentally with:
Acquisitions that make up a growing portfolio of revenue-producing companies already operating in the CBD/hemp space
A number of property assets in Washington State and Oregon
The expansion of its footprint into markets that provide a sustainable operating environment and allow New Age Brands to maintain its goal of becoming a worldwide "brand."
With continued success in these three areas of growth, this small company's future in a burgeoning industry looks very attractive.
When asked about New Age Brand's focus moving forward, management said that it has decided to move its attention and resources into acquiring already proven business entities and businesses that it feels have strong growth potential and strong core management in the hemp and CBD space.
Additionally, the company says it's currently working with a number of science teams to develop innovative products that New Age Brands is confident can accompany its growing portfolio while also standing out on their own in the industry.
Currently, New Age Brands has two subsidiaries that it recently acquired:
We Are Kured or "Kured" (www.wearekured.com) and Drink Fresh Water (www.drinkfreshcbd.com). Both companies are generating revenue with the sale of products in the hemp and CBD industries.
Through its subsidiary, Kured, New Age Brands is building an innovative online CBD and lifestyle company. Kured has partnered with best-in-class hemp cultivators, edible manufacturers, and cutting edge product formulators to develop, market and distribute a number of CBD products. In addition to filling orders in the U.S. and Canada, Kured recently expanded into South America where it plans to distribute products throughout the region with "Kured Latin America LLC."
Its other subsidiary, Drink Fresh Water, is a California-based company created by a group of industry leaders that offers New Age Brands immediate entry into the CBD-infused beverage industry with its flagship product, "Fresh Water." The CBD-infused, nano-amplified alkaline water can be found in retail stores in 35 different states across the U.S., and with the drink's success, management has already expressed that it expects to expand the company's lineup of products by adding additional SKUs in the near future.
New Age Brands is also growing a portfolio of properties that are proving to be revenue-producing assets for the company as well. Management at New Age Brands says they look to acquire properties that have strong, proven and permitted operating tenants, and if the company chooses to acquire a property, they will implement their industry-leading expertise to optimize the potential revenue and overall net profit with that asset.
The company says the properties it recently acquired in Oregon have already proven to be a great acquisition that they were able to take advantage of, while they're still evaluating the properties the company owns in Washington State to decide the best course of action for these properties.
New Age Brands acts as the "landlord" of the two properties it acquired in Oregon—the Cave Junction, Oregon, property and the Portland, Oregon, property where New Age Brands generates almost $250,000 annually in rent payments alone.
A state of the art outdoor and greenhouse cannabis cultivation facility is operated by Trellis Farms on the company's Cave Junction property, and the Portland property has been home to an established dispensary for the last four years.
New Age Brands has laid out a plan that, so far, management has done a great job of sticking to, while being flexible enough to expand upon that plan when necessary. Its expansion into Latin America is one such example of the company not being afraid to grow where they feel there is a sustainable operating environment.
Executives at New Age Brands feel that due to the uniqueness of the company's focus on hemp, regardless of being housed in the United States, they are not hand cuffed to the same onerous and expensive state-by-state marijuana licensing laws. Simply put management sees New Age Brands as a global brand. The company feels strongly that the wave of the future is in the hemp derived CBD market, and they will be building a plethora of brands to gain as much market share as possible in the industry.
When asked to offer a report card of sorts on the plan that management has put into place, we were told that Kured is growing at a faster pace than they expected with profit margins increasing by 100 percent with its in-house manufacturing. The newly acquired Oregon properties are a great monthly revenue addition. Fresh Water is already in 35 states and by adding its own team's expertise, they are hopeful to be generating sales of Fresh Water on 2 continents by the end of 2018. The company says they're in talks with other existing CBD brands to potentially acquire, and New Age Brands also has ideas for its own CBD brands, which it says will be first to market.
Market Outlook
The cannabis market has grown at a tremendous pace over the recent years and as such, the industry has established itself a major global market. According to data compiled by Grand View Research, the global legal cannabis market is projected to reach USD 146.4 Billion by the 2025. It is also expected to grow at a CAGR of 34.6%. The market itself is witnessing a widespread legalization movement due to the growing adoption of the plant within the medical sector. Cannabis is being used heavily around the global for medical applications and treatments for maladies such as cancer, mental disorders, chronic pain, and others. However, the recreational market is thriving as well due specifically to the U.S. and Canada. States like California, Colorado, and Nevada are expected to propel the recreational sector forward at an encouraging rate.
The acceleration of research and development has led to new products within the market, enhancing consumer experiences. The research suggests that the industry is expecting strong exchanges of technological knowledge and information. Meanwhile, as countries like Canada, the U.S., Germany, and Australia lead the market in sales, countries like Israel are focusing on research and technology development to further expand within the industry. Additionally, there are various new forms of technology being introduced into the cannabis sector, such as virtual reality, payment solutions, and medical devices. "That's why we firmly believe that technology stands at the center of the industry's advancement and growth," said Ben Curren Chief Executive Officer of Green Bits, "This innovation will continue to generate market growth, improve public perception, protect public health and safety and enhance the implementation of state programs and regulations.
Technical Analysis
Those of you who love "buying the dip" should be licking your chops at NWGFF.
The Company is down nearly +75% from its 52-week high of $0.184.
That being said, NWGFF appears to have been building momentum over the past few days, and we believe a bullish reversal is just starting to take shape.
A reversal all the way back to its 52-week high would net members gains of over +284%!
We did our own chart analysis, and see the potential for a more realistic move of around +60%!
No matter which way you slice it, NWGFF looks like the next potential double-digit winner in our book.
As such, we are urging all members to start their research now, and consider grabbing up a position in NWGFF tomorrow morning at 9:30AM EST!
(*Remember to use a basic Stop-Loss Order or more advanced Stop-limit Order to protect your gains, as well as limit possible losses.)
Best Regards,
The TopMarketGainers Team
Don't Miss Our Next Huge Winner...
Text 'GAINS' to '67076'
to have our Trade Alerts
Delivered Direct
to your Cell Phone.
(There is no charge.
Msg&data rates may apply.)
DISCLAIMER
This newsletter is a paid advertisement, not a recommendation nor an offer to buy or sell securities. This newsletter is owned, operated and edited by both MJ Capital, LLC and PennyStockLocks, LLC. Any wording found in this e-mail or disclaimer referencing to “I” or “we” or “our” refers to MJ Capital, LLC and PennyStockLocks, LLC. Our business model is to be financially compensated to market and promote small public companies. By reading our newsletter and our website you agree to the terms of our disclaimer, which are subject to change at any time. We are not registered or licensed in any jurisdiction whatsoever to provide investing advice or anything of an advisory or consultancy nature, and are therefore are unqualified to give investment recommendations. Always do your own research and consult with a licensed investment professional before investing. This communication is never to be used as the basis of making investment decisions, and is for entertainment purposes only. At most, this communication should serve only as a starting point to do your own research and consult with a licensed professional regarding the companies profiled and discussed. Conduct your own research. Companies with low price per share are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold our site, its editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters or on our website.
We do not advise any reader take any specific action. Losses can be larger than expected if the company experiences any problems with liquidity or wide spreads. Our website and newsletter are for entertainment purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter and on our website may be based on end-of-day or intraday data. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. If we own any shares we will list the information relevant to the stock and number of shares here. MJ Capital does NOT own any shares of the companies mentioned herewithin, nor intends to buy any in the future.
MJ Capital’s business model is to receive financial compensation to promote public companies. We have been compensated twelve thousand five hundred dollars by third party to conduct investor relations advertising and marketing for NWGFF. Any compensation is a major conflict of interest in our ability to be unbiased. Therefore, this communication should be viewed as a commercial advertisement only. We have not investigated the background of the hiring third party or parties. The third party, profiled company, or their affiliates likely wish to liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices. Any non-compensated alerts are purely for the purpose of expanding our database for the benefit of our future financially compensated investor relations efforts. Frequently companies profiled in our alerts may experience a large increase in volume and share price during the course of investor relations marketing, which may end as soon as the investor relations marketing ceases. The investor relations marketing may be as brief as one day, after which a large decrease in volume and share price is likely to occur. Our emails may contain forward looking statements, which are not guaranteed to materialize due to a variety of factors.
We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters and on our website is believed to be accurate and correct, but has not been independently verified and is not guaranteed to be correct. The information is collected from public sources, such as the profiled company’s website and press releases, but is not researched or verified in any way whatsoever to ensure the publicly available information is correct. Furthermore, MJ Capital often employs independent contractor writers who may make errors when researching information and preparing these communications regarding profiled companies. Independent writers’ works are double-checked and verified before publication, but it is certainly possible for errors or omissions to take place during editing of independent contractor writer’s communications regarding the profiled company(s). You should assume all information in all of our communications is incorrect until you personally verify the information, and again are encouraged to never invest based on the information contained in our written communications. The information in our disclaimers is subject to change at any time without notice.
AGHI: This past +156% winner looks ready to RUN WILD once again!=====================
AGHI Agora Holdings Inc.
Alert Price: $0.1195
Float: 29.48M
Chart Analysis
========================
Members,
It's already been a profitable week for us.
Friday's pick QBIO continued its bullish reversal, hitting a high $2.43 today, making it a two-day +37% winner for our members.
Our pick from January 8th, ANFI, also had a big day, hitting a high of $1.07, a gain of over +143% from our $0.44 alert price.
Congrats to all those who took action on our buy calls, and secured the up to +180% in total profits that our alerts provided.
Now we would like to focus our attention to a past triple-digit winner that appears to be back in the buy-zone, and ready for a bullish reversal of its own.
Please turn your immediate attention to AGHI (Agora Holdings Inc.).
The last time we brought this highly diversified entertainment and media enterprise company to your attention shares were trading at nearly the exact same price as they are right now.
Within 3-weeks time, shares of AGHI had more than doubled from our alert price to the tune of over +156% in multi-day gains.
We have been keeping a close eye on this ticker ever since then, and now could be the perfect time to once again start building a position AGHI.
Today, AGHI closed under 12-cents for the first time this year!
This could be the perfect entry point for traders looking to cash in on what could be a highly profitable bullish reversal in the making.
The Company has made several big announcements since we've last covered it, all of which could be considered bullish catalysts heading into Q1 2019.
Announced the December 2018 appointment of Mr. Oleksandr Bondarenko, 11.24% shareholder of the Company and 24.5% shareholder of the Company’s controlled Hong Kong based subsidiary, eSilkroad Network Limited, as the Company’s Chief Operating Officer.
Its 51% owned subsidiary, eSilkroad Network Limited (“ESRL”), has completed the first round of landing page prototype testing with Kitsoft of Ukraine, and is moving to conclude second stage testing of a series of revised prototype pages which commenced mid-December, 2018.
eSilkroad Network Limited, entered into a Letter of Intent with Beijing Nuozhou Technology Company Ltd., the creator of www.ono.chat, a blockchain social media platform with over 3.8 million users across the globe. In order to pursue a strategic partnership.
At just $0.1195 per share, AGHI is trading at the lower-end of its 52-week price channel, and well off its 52-week high of $0.40.
We've already witnessed AGHI's breakout potential.
With an upside of over +234%, AGHI should be the top ticker on your watchlist.
This was one of our biggest winners of 2018!
Let's hope history repeats itself in 2019!
That being said, we ask that all members read our full profile, start their research now, and consider grabbing up a position in AGHI tomorrow morning at 9:30AM EST!
About Agora Holdings Inc.
Agora Holdings Inc., together with its subsidiary Geegle Media and affiliates, is presently an entertainment and media enterprise. Agora Holdings Inc. brings together media and technology, driving innovation to enhance online entertainment in five business segments: media networks, TV, studio entertainment, consumer products and interactive media. Agora is seeking to expand its portfolio to include dynamic and interactive web-based networking platforms for global implementation.
Divisions:
Esilkroad Network Limited
Esilkroad Network Limited and its subsidiary, eSilkroad of Ukraine, is a conceptual B2B platform that intends to make the interaction between businesses and non-profit organizations throughout the world faster, more effective, and less costly. eSilknet, the web-based platform under development by eSilkroad Network Limited will allow users to search for and communicate with business partners, search for and post proposals for investment and opportunity in developing projects globally, place advertisements for products and services, communicate securely on trade and project development and attract professional services for specific project-based needs. The concept of eSilknet is in line with the original concept of the “silkroad”, facilitating trade and commerce between countries, only a global scale. eSilkroad Network is currently negotiating the acquisition of complementary platform, “eSilktrade” which has been under development privately in Shanghai for several years. eSilkroad Network believes the combined expertise of its Ukraine based eSilkroad development team and the existing team at eSilktrade can integrate the live trade platform into its B2B site further enhancing value for its users. www.esilknet.com
Software Development
GEEGLE MEDIA
Geegle Media’s project management is a value-driven approach that allows the company to deliver high-priority, high-quality work and look like rock stars to their stakeholders. Its nothing like the plodding, costly and error-prone approach to project management, which has delivered inconsistent results for years.
Software projects change constantly. When customers are expected to finalize requirements before they can test-drive the prototypes, overhead and long delays often cripple the project. Geegle Media Management is about embracing change, even late in the development stage. It’s about delivering the features with the greatest business value first, and having the real-time information to tightly manage cost, time and scope.
Geegle Media Project Management reduces complexity by breaking down the many-months-long cycle of building requirements for the whole project, building the entire product and then testing to find hundreds of product flaws. Instead small, usable segments of the software product are specified, developed and tested in manageable, two- to four-week cycles.
Social Media/Marketing
FLEET
Takes Your social media campaigns to the next level!
Frame gives You full control over Your social media campaigns
Login using Facebook Login using Twitter Login using Instagram
Manage all of Your social media channels in one place
Schedule your posts for the right time
Prepare your posts and prepare their share in the future.
Save time and efforts.
Publish posts on all social accounts you need.
Generate professional infographic reports
Use their analytic tools to generate professional presentations for social media performance in special designed templates
Follow your best friends more intensive
Follow what your social media friends upload and choose what posts to see
Recent Developments
Agora Holdings Inc. Subsidiary, eSilkroad Network Limited, Completes First Series of Prototype Testing and Commences Second Stage Testing Protocols, Implementing Feedback From Initial Test Group Results
In late December, AGHI announced that further to our press announcement of December 3, 2018, its 51% owned subsidiary, eSilkroad Network Limited (“ESRL”), has completed the first round of landing page prototype testing with Kitsoft of Ukraine, and is moving to conclude second stage testing of a series of revised prototype pages which commenced mid-December, 2018.
Between December 3 and December 10, 2018, a total of 87 companies from around the globe participated in our initial Unmoderated Remote Usability Testing (URUT) of over 30 key prototype pages for our developing B2B platform intended to make the interaction between businesses and non-profit organizations throughout the world faster, more effective, and less costly. Test participants provided feedback on various aspects of the prototype pages including concept, functionality and appeal. Our engaged operational partners, Kitsoft of Ukraine, and design partners, Rain Partners of Ukraine, received real-time test results and immediately implemented feedback from test participants in order to provide revised prototype pages for second round testing which commenced on the 13th of December 2018. The Company intends to carry out ongoing prototype testing and focus groups during the month of January 2019, ultimately exposing over 300 corporations to our landing page prototypes.
eSilkroad Network’s technical director, Alexander Lobko, commented, “We were extremely pleased with the first round of test results for our innovative B2B social network, ‘eSilknet’. All process testing was completed in accordance with our original concept development and assessment protocol which allows for immediate implementation of test feedback so that we can quickly and efficiently move to each subsequent testing phase. We are looking forward to releasing more details of our test results as we complete each trial phase. Of the initial 87 corporate participants, over 65% were corporate entities from the People’s Republic of China. We expect the Chinese market to be a key userbase for our B2B network, opening trade and communication channels for Chinese corporations world-wide.”
Market Outlook
The social media market has been hot for the past few years. Companies have realized social media could be one of the main drivers of growth. However, with the Facebook scandal, it’s opened the market up for new competitors to join in on the action.
According to Research and Markets, B2B e-commerce sales are forecast to be over two times higher than global online retail sales. That said, there is immense growth potential in the market.
A report from Forrester Research in 2017 estimated business-to-business (B2B) ecommerce transactions would reach $1.2 trillion by 2021.
Frost & Sullivan has even loftier expectations with B2B ecommerce hitting $6.6 trillion by 2020.
Over 400,000 organizations are already shopping on Amazon Business with B2B.
Technical Analysis
As we enthusiastically stated above, AGHI has a well recorded history of breaking out for big gains.
The last time we brought this ticker to your attention, shares ran-up over +156% in about 3-weeks time!
More recently, on January 14th, shares of AGHI ran-up over +34% in a just a single-session.
We've done our very own chart analysis, and see the potential for a move of +99%!
If you've been following our newsletter, you know that we've been right on the money with all of our alerts this year so far.
We are feeling confident that AGHI will be the next big mover for our members.
As such, we are urging all members to start their research now, and consider grabbing up a position in AGHI tomorrow morning at 9:30AM EST!
(*Remember to use a basic Stop-Loss Order or more advanced Stop-limit Order to protect your gains, as well as limit possible losses.)
Best Regards,
The TopMarketGainers Team
Don't Miss Our Next Huge Winner...
Text 'GAINS' to '67076'
to have our Trade Alerts
Delivered Direct
to your Cell Phone.
(There is no charge.
Msg&data rates may apply.)
DISCLAIMER
This newsletter is a paid advertisement, not a recommendation nor an offer to buy or sell securities. This newsletter is owned, operated and edited by both MJ Capital, LLC and PennyStockLocks, LLC. Any wording found in this e-mail or disclaimer referencing to “I” or “we” or “our” refers to MJ Capital, LLC and PennyStockLocks, LLC. Our business model is to be financially compensated to market and promote small public companies. By reading our newsletter and our website you agree to the terms of our disclaimer, which are subject to change at any time. We are not registered or licensed in any jurisdiction whatsoever to provide investing advice or anything of an advisory or consultancy nature, and are therefore are unqualified to give investment recommendations. Always do your own research and consult with a licensed investment professional before investing. This communication is never to be used as the basis of making investment decisions, and is for entertainment purposes only. At most, this communication should serve only as a starting point to do your own research and consult with a licensed professional regarding the companies profiled and discussed. Conduct your own research. Companies with low price per share are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold our site, its editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters or on our website.
We do not advise any reader take any specific action. Losses can be larger than expected if the company experiences any problems with liquidity or wide spreads. Our website and newsletter are for entertainment purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter and on our website may be based on end-of-day or intraday data. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. If we own any shares we will list the information relevant to the stock and number of shares here. MJ Capital does NOT own any shares of the companies mentioned herewithin, nor intends to buy any in the future.
MJ Capital’s business model is to receive financial compensation to promote public companies. We have been compensated twelve thousand five hundred dollars by Awareness Consulting Network to conduct investor relations advertising and marketing for AGHI. We have been previously compensated ten thousand dollars by ACN LLC. to conduct investor relations advertising and marketing for AGHI -which has expired. We have been previously been compensated five thousand dollars by World Wide Holdings dba Invictus Resources to conduct investor relations advertising and marketing for ANFI -which has expired. We have been previously compensated ten thousand dollars by ACN LLC. to conduct investor relations advertising and marketing for QBIO-which has expired. Any compensation is a major conflict of interest in our ability to be unbiased. Therefore, this communication should be viewed as a commercial advertisement only. We have not investigated the background of the hiring third party or parties. The third party, profiled company, or their affiliates likely wish to liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices. Any non-compensated alerts are purely for the purpose of expanding our database for the benefit of our future financially compensated investor relations efforts. Frequently companies profiled in our alerts may experience a large increase in volume and share price during the course of investor relations marketing, which may end as soon as the investor relations marketing ceases. The investor relations marketing may be as brief as one day, after which a large decrease in volume and share price is likely to occur. Our emails may contain forward looking statements, which are not guaranteed to materialize due to a variety of factors.
We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters and on our website is believed to be accurate and correct, but has not been independently verified and is not guaranteed to be correct. The information is collected from public sources, such as the profiled company’s website and press releases, but is not researched or verified in any way whatsoever to ensure the publicly available information is correct. Furthermore, MJ Capital often employs independent contractor writers who may make errors when researching information and preparing these communications regarding profiled companies. Independent writers’ works are double-checked and verified before publication, but it is certainly possible for errors or omissions to take place during editing of independent contractor writer’s communications regarding the profiled company(s). You should assume all information in all of our communications is incorrect until you personally verify the information, and again are encouraged to never invest based on the information contained in our written communications. The information in our disclaimers is subject to change at any time without notice.
$QBIO is our New Low-float, BioTech Alert w/ MASSIVE UPSIDE!=====================
QBIO (Q BioMed Inc.)
Alert Price: $1.77
Float: 9.2M
Investor Presentation
Fact Sheet
Shareholder Update
Corporate Update Video
========================
Members,
We hope you enjoyed the over +23% in realistic profit that Wednesday's alert provided.
Earlier today, we told you that we had identified a company operating in the biotech space that looks primed and ready to breakout for some significant gains in the immediate future.
Please turn your immediate attention to QBIO (Q BioMed Inc.).
This biomedical acceleration and development company appears to be extremely undervalued and oversold at the moment, and we want our members to be on board for what we believe will be an epic bullish reversal in Q1 2019.
The company has several bullish catalysts working in its favor that we believe will help make it a significant winner for our members:
The biotech sector as a whole has been on fire, and is up over +20% since December 24th.
Strong corporate leadership led by CEO Denis Coran.
A growing pipeline and strategy that mitigates risk & drives shareholder value.
Acquired the metastatic skeletal cancer palliation drug, Metastron™, from GE Healthcare.The agreement gives QBIO ownership of the brand, trademarks and market authorizations in 22 countries. In addition, all historical and current sales and distribution data related to those market authorisations will be assigned or transferred to QBIO to allow for as seamless a transition as possible in all markets.
QBIO anticipates Metastron™ to start generating revenue in 1H 2019, with gross palliation revenue expected to be $20M-$40m p/a in year 3.
QBIO's QBM-001 treatment for pediatric non-verbal disorder has $5B in global market potential.
QBIO believes that it will complete formulation and manufacturing of QBM-001 by the end of the second quarter of 2019, after which it will file an investigational new drug (IND) application with the FDA. The company is hopeful that QBM-001 may receive the relevant designations from the FDA that could accelerate the development timeline. Assuming authorization from the FDA for the IND, the company believes it could begin a pivotal clinical trial of QBM-001 in the third quarter of 2019, which could lead to reviewed interim data as early as the first quarter of 2020.
Now what has us really excited about QBIO, is what we heard during CEO Denis Coran's audio interview with SmallCapVoice.com on January 15th.
At around the twelve minute mark, Mr. Coran hints at an upcoming FDA approval for QBIO's south Texas manufacturing facility.
Once approved QBIO can start producing Metastron™ commercially for sale in the U.S. and then internationally!
This drug is a substantial opportunity for QBIO. A very similar drug with a very narrow indication currently does almost $800 million a year in revenue!
This would be huge news, and could have a major impact on QBIO's stock price.
This is a great and informative interview, and it should get you excited about the incredible opportunity that QBIO presents you at the moment.
We would also like to mention, that just like several of our past big winners, QBIO trades on the OTCQB Venture Marketplace.
Securities trading on OTCQB have higher reporting and certification standards, which tends to lead to increased liquidity, investor confidence, as well as enhanced shareholder value.
This has the potential to be our next big winner of Q1 2019.
As such, we are urging all members to read our full profile, start their research now, and consider grabbing up a position in QBIO tomorrow morning at 9:30AM EST!
About Q BioMed
Q BioMed, Inc. is a biomedical acceleration and development company. They are focused on licensing and acquiring biomedical assets across the healthcare spectrum. Q BioMed is dedicated to providing these target assets the strategic resources, developmental support and expansion capital they need to meet their developmental potential so that they can provide products to patients in need.
QBIO approaches biopharmaceutical development from a nontraditional angle. Rather than strictly devoting its resources to internal development, the company licenses what it deems to be undervalued biomedical assets in order to accelerate the achievement of clinical and commercial milestones. The company has five assets in its pipeline, led by its cancer palliation program, and diversified across multiple areas of significant medical need, including developmental nonverbal disorder, liver cancer and glaucoma.
Q BioMed Unlocks Undiscovered Biomedical Value
Targets assets entering validation, clinical stages or commercialization leading up to value creating inflection points
Deploys performance-based capital and resources to accelerate the development of an asset milestone achievement by its management
Licenses or acquires the assets and works together to create valuation growth
How Q BioMed Accelerates Biomedical Technology Development
Unlocks capital in US public markets to fund the development of assets
Makes liquid investments in high-value assets that can produce exponential returns
Diversifies risk over several therapies in various stages of development and deploys performance-based capital only
Accelerates its asset’s development with management and advisory teams' expertise, experience, and industry relationships
Recent Developments
Q BioMed Adds Clinical Psychologist at Yale's Child Study Center, Dr. Pamela Ventola to Advisory Committee for QBM-001
On Wednesday, QBIO announced that Pamela Ventola Phd, from Yale University has joined its Advisory Committee for its QBM-001 clinical program. QBM-001 is being developed and tested for the treatment of minimally verbal or non-verbal toddlers with an Autism Spectrum Disorder (ASD).
Dr. Ventola serves as a clinical psychologist and assistant professor at Yale University's Child Study Center with a clinical and research focus in: behavioral treatment for autism spectrum disorders, Pivotal Response Treatment (PRT), biological markers of treatment response, and dissemination and implementation of treatment for ASD. Dr. Ventola also directs the Rare Disease and Pediatric Center of Excellence at Cogstate, a publicly traded company that supports pharmaceutical companies in clinical trial design, methodologies, and rater training services as it relates to cognitive and other clinical outcome assessments.
Strategy and Clinical Trial Design Specialist Provides Expertise for the Clinical Trial Design and Regulatory Requirements of QBM-001
QBM-001 Developed to Treat a Pediatric Non-Verbal Disorder which impacts 18,000 children each year in the U.S and a similar amount in Europe.
Market Outlook
The global cancer therapeutics market should reach $172.6 billion by 2022 from $121 billion in 2017 at a compound annual growth rate (CAGR) of 7.4%, from 2017 to 2022.
Bone Metatases from Prostate and Breast Cancer
450,000 new breast and prostate cancer diagnoses each year
1 in 3 people will develop bone metastases from the spread of breast and prostate cancer
Pediatric Non-Verbal Disorder
Among the >60,000 US children who develop Autism Spectrum Disorders (ASD)
every year,
20,000 become nonverbal and will have to rely on assisted living for the rest of
their life.
Liver Cancer
700,000 patients worldwide
Short 1-year survival rate
Estimated 39,230 adults in the US will be diagnosed every year
Glaucoma
60 million patients worldwide
8 million with bilateral blindness
Typically no early warning signs
Therapy only slows progression, no cure
Technical Analysis
QBIO's stock price has been on a downtrend as of late, but we believe that the bottom is in, and that the upside potential far outweighs the downside risk.
CEO Denis Coran addressed the stocks decline in his most recent shareholder update, and we feel confident that he and his management team are well on their way towards reversing this downtrend.
QBIO is trading well off its 52-week high, with plenty of room to the upside.
In fact, a run back to its 52-week high of $4.50 would represent a gain of over +154%!
The float on QBIO is also very thin at just $1.77, so don't be surprised if we see a big move from this ticker tomorrow.
As we stated above, this could easily be our next big winner of Q1 2019.
We are urging all members to start their research now, and consider grabbing up a position in QBIO tomorrow morning at 9:30AM EST!
(*Remember to use a Stop-Loss Order or basic Limit Order to protect your gains, as well as limit possible losses.)
Best Regards,
The TopMarketGainers Team
Don't Miss Our Next Huge Winner...
Text 'GAINS' to '67076'
to have our Trade Alerts
Delivered Direct
to your Cell Phone.
(There is no charge.
Msg&data rates may apply.)
DISCLAIMER
This newsletter is a paid advertisement, not a recommendation nor an offer to buy or sell securities. This newsletter is owned, operated and edited by both MJ Capital, LLC and PennyStockLocks, LLC. Any wording found in this e-mail or disclaimer referencing to “I” or “we” or “our” refers to MJ Capital, LLC and PennyStockLocks, LLC. Our business model is to be financially compensated to market and promote small public companies. By reading our newsletter and our website you agree to the terms of our disclaimer, which are subject to change at any time. We are not registered or licensed in any jurisdiction whatsoever to provide investing advice or anything of an advisory or consultancy nature, and are therefore are unqualified to give investment recommendations. Always do your own research and consult with a licensed investment professional before investing. This communication is never to be used as the basis of making investment decisions, and is for entertainment purposes only. At most, this communication should serve only as a starting point to do your own research and consult with a licensed professional regarding the companies profiled and discussed. Conduct your own research. Companies with low price per share are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold our site, its editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters or on our website.
We do not advise any reader take any specific action. Losses can be larger than expected if the company experiences any problems with liquidity or wide spreads. Our website and newsletter are for entertainment purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter and on our website may be based on end-of-day or intraday data. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. If we own any shares we will list the information relevant to the stock and number of shares here. MJ Capital does NOT own any shares of the companies mentioned herewithin, nor intends to buy any in the future.
MJ Capital’s business model is to receive financial compensation to promote public companies. We have been compensated ten thousand dollars by Awareness Consulting Network to conduct investor relations advertising and marketing for QBIO. Any compensation is a major conflict of interest in our ability to be unbiased. Therefore, this communication should be viewed as a commercial advertisement only. We have not investigated the background of the hiring third party or parties. The third party, profiled company, or their affiliates likely wish to liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices. Any non-compensated alerts are purely for the purpose of expanding our database for the benefit of our future financially compensated investor relations efforts. Frequently companies profiled in our alerts may experience a large increase in volume and share price during the course of investor relations marketing, which may end as soon as the investor relations marketing ceases. The investor relations marketing may be as brief as one day, after which a large decrease in volume and share price is likely to occur. Our emails may contain forward looking statements, which are not guaranteed to materialize due to a variety of factors.
We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters and on our website is believed to be accurate and correct, but has not been independently verified and is not guaranteed to be correct. The information is collected from public sources, such as the profiled company’s website and press releases, but is not researched or verified in any way whatsoever to ensure the publicly available information is correct. Furthermore, MJ Capital often employs independent contractor writers who may make errors when researching information and preparing these communications regarding profiled companies. Independent writers’ works are double-checked and verified before publication, but it is certainly possible for errors or omissions to take place during editing of independent contractor writer’s communications regarding the profiled company(s). You should assume all information in all of our communications is incorrect until you personally verify the information, and again are encouraged to never invest based on the information contained in our written communications. The information in our disclaimers is subject to change at any time without notice.
We're turning BULLISH on #Bitcoin | $BTC for the Next Few Weeks!We're turning BULLISH on #Bitcoin | $BTC for the Next Few Weeks!
KNHBF: Could this be the start of the Next +100pct Rally? =====================
Our New Pick is: KNHBF
Current Price: $0.25
Investor Presentation
========================
Members,
Earlier this week, we told you that we were looking for the perfect trade idea that could deliver easy profits during this brutal bear market.
After scanning the market for quite some time, we've decided not to take any chances, and just go with a company that has proven itself to be a winner each and every time we've alerted it to our members.
Please turn your immediate to attention back to our #1 cannabis play of 2018 KNHBF (ICC International Cannabis Corp.)
We plan on ending this 2019 on a high-note with this past +100% winner!
We first brought KNHBF to your attention back on September 27 when it was flying under the radar at just $0.44 per share.
In less than two week's time, shares of KNHBF rallied as high as $0.90, representing multi-day gains of up to +104.55% for our members.
We are just as excited about KNHBF now as we were back in late September.
In fact, the upside is even more attractive now.
Shares of KNHBF traded down to $0.25 yesterday, creating the perfect buying opportunity for those looking to cash in on the cannabis boom at a ground floor price.
We've been keeping a close eye on this red-hot cannabis play, and we believe that right now could be the perfect entry point for those looking for a piece of this cannabis company committed to growth
Here's why...
On Oct. 17, Canada becomes the second and largest country with a legal national marijuana marketplace.
KNHBF has been issued the FIRST EVER medical cannabis cultivation license by the Greek government.
Broke ground on Colombian Centre of Excellence for Cannabis Propagation; Marking Initialization of 10-Hectare Cannabis Park
Announced the creation of the world’s first fully electronic cannabis marketplace through a partnership with GreenTree International, the parent company of Amercanex, which operates a secure Electronic Cannabis Market (ECM) called ACExchange.
Completed 100% Acquisition of Enigma Unipessoal LDA - a company who controls one of the first hemp licenses issued in Portugal
Entered into a definitive agreement to acquire 100 percent of Balkan Cannabis Corp (“Balkan Cannabis”). Balkan Cannabis controls Macedonian medical Cannabis cultivation and extraction licenses, as well as Bulgarian medical Cannabis and hemp cultivation licenses.
Increased their European distribution footprint by over 1,300 pharmacies
As you can see KNHBF is deeply committed to strengthening its grip on the European cannabis market.
With a population twice the size of the US and Canada combined, and a cannabis market still in its relative infancy, Europe presents an enormous opportunity.
KNHBF has been dropping big news almost daily, and we would not be surprised if the Company announced another major milestone today.
This could be one of your last chances to start a position in KNHBF for a under $1 per share....
That being said, we are urging all members to start their research on this past +100% winner immediately, and be ready to take action this morning at 9:30AM EST!
About ICC International Cannabis Corp.
Via its diversified portfolio of companies and subsidiaries, ICC International Cannabis intends to further establish itself as a international Cannabis industry consolidation platform. The Company’s mission is to inspire holistic wellness by augmenting the design, development and production of the world’s most innovative and best performing Cannabis products and facilities.
Through its subsidiaries, KNHBF has agreements in place for European-based pharmaceutical distribution, wholesale importation, research and development, as well as working interests in industrial hemp licenses in Greece, licenses to cultivate, produce, distribute, store, and export Cannabis and Cannabis derivatives in Colombia, the Kingdom of Lesotho, Africa and Denmark.
Company Highlights:
110 clients representing approximately 36,300 pharmacies in 16 countries
13 hectacres of optimal agricultural land dedicated to cannabis cultivation located in Funza, Colombia
16 acres of fertile agricultural land dedicated to industrial cultivation and CBD extractuib siturated within the Greek prefecture of Imathia
2,400 pharmacies included in their distribution portfolio of independent and corporate pharmacies across South Africa
55k sq/ft fully automated IMC-GAP, ISO:9001 and European GMP compliant greenhouse facility to be constructed in Denmark
9 licenses or cultivation, spanning three continents
KNHBF's Current Holdings
Marathon Global Inc.
Marathon Global has an exclusive agreement with Cosmos Holdings, a European based pharmaceutical distributor, to procure and distribute medical cannabis products and all cannabis derivatives for clients of Cosmos in approved countries within its distribution network of 110 clients, representing approximately 35,000 pharmacies in 16 countries. Marathon Global brings an unparalleled ability to supply the overwhelming demand for cannabis and cannabis extracts in Europe as Cosmos brings generations worth of experience and relationship to Kaneh Bosm. This distribution strategy carries on the Company’s existing distribution business through its unique BioCanna ADM retail system.
EU Cannabis Corp.
EU Cannabis has an option to acquire a 90-per-cent working interest in industrial hemp licenses held by Cannatec Greece A.E. Cannatech currently holds three licenses covering a total of 16 acres situated within the Greek prefecture of Imathia. These licenses were granted to Cannatec by the Hellenic Republic Ministry of Agricultural Development and Food, and permit EU Cannabis to cultivate, manufacture, distribute and export industrial hemp and its many cannabidiol (CBD) derived extracts. Greece boasts over 300 days of unadulterated sunshine per year, resulting in attractive climate for outdoor industrial hemp cultivation. The alignment of the company’s existing distribution channels, revolutionary
ADM retail system along with EU Cannabis’s robust extraction capabilities will assist in appeasing an expanding appetite for functional CBD products within the European Union.
Danavian Cannabis Ltd.
Danavian controls licenses for cannabis cultivation and manufacturing in the Kingdom of Denmark. Kaneh Bosm’s entry into Denmark mirrors industry peers such as Canopy Growth Corporation, Green Organic Dutchman Holdings, Aurora Cannabis Inc. and CannTrust Holdings.
Danavian has engaged an Israeli cannabis organic cultivation and management company, Sababa Sciences Inc. (“Sababa Sciences”). Sababa Sciences will provide end-to-end management including the implementation of advanced Israeli agricultural technologies for high quality medical cannabis treatments. Danavian and Sababa Sciences have designed a 55,000 square foot, fully automated greenhouse facility that will meet IMC-GAP, ISO:9001 and European GMP standards. Finished cannabis and cannabis derivatives produced by Danavian will be sold through Denmark’s retail pharmacy network.
Danavian holds claim to premier European cannabis assets; domiciled in a jurisdiction with a highly skilled agriculture and manufacturing workforce. Davavian also boasts various industry relationships that will complement future development potential throughout Scandinavia. Continued development of Danavian’s Danish cannabis portfolio will help serve both local and export market demand. Danavian is tactically positioned in immediate proximity to Germany, allowing for direct imports of CBD products, as well as medical cannabis flower.
CanAfrica Holdings
CanAfrica holds a license to cultivate, manufacture, supply, hold, import, export and transport cannabis and derivative products. The Kingdom of Lesotho, Africa, has an ideal climate for low-cost greenhouse cannabis production. It averages over 300 days of sunshine annually. Lesotho was the first African nation to legalize medical cannabis in 2017.
The Company believes that by establishing a presence in Africa, it will extend its current business model and allow the company to produce its own products to push through its unique and substantial European distribution networks and into its award-winning BioCanna ADM automated retail system.
Aricannabis
Aricannabis works on an exclusive basis with NuCare Health (“NuCare”) to provide Cannabis products to over 2,800 independent and corporate pharmacies across South Africa. NuCare also provides their medical partners with the following:
Access to innovative consumer products;
Strategic partnerships with key suppliers;
Management of channel pressure; and
Educational and training resources.
The alignment of the Kaneh Bosm’s existing African cultivation capabilities and distribution channels, complemented by these new established marketing and distribution channels will augment the Company’s African seed-to-sale objectives.
Cannabis Medical Group SAS
Cannabis Medical Group SAS, a Colombian entity that holds licenses to cultivate, produce, hold, sell and export cannabis and cannabis derivatives.
Colombia has become a highly sought-after jurisdiction for cannabis cultivation activities as it has a world-leading combination of broad public and private sector acceptance, ideal growing conditions, and a massive addressable market.
Cannabis Medical Group previously acquired 13 hectares of optimal agricultural land located in Funza, the heart of the Bogota savanna, which is also one of the safest areas in Colombia. It is conveniently located within a 20-kilometre drive to Bogota’s international airport. The lease on this land has been prepaid for a period of 10 years.
BioCanna ADM Retail System
The BioCanna ADM retail system is an intelligent automated retail kiosk for the dispensing of Cannabis and related products in both medical and commercial markets.
The BioCanna ADM retail system offers a solution to many of the concerns related to controlling access to ensure that only properly identified and qualified clients can obtain marijuana products. With strict regulations in place throughout the North American Cannabis market the BioCanna ADM could offer Cannabis retailers a means to meet and surpass regulated requirements. The BioCanna ADM retail system is unique in this sector as it encompasses the 5 crucial elements identified by Ret. Major Neill Franklin, executive director of LEAP for safe, reliable and successful automated Cannabis retail. Those elements are:
Access control (no minors or un-prescribed patients)
Purchase volume control (monthly or daily quantity limits)
Secure storage of product (climate controlled and theft proof)
Transactional oversight by regulators via software monitoring
Proven track record in a controlled substance/products environment
The proprietary software system, which operates the BioCanna ADM, offers regulatory bodies the ability to dynamically observe transactions in real-time at every Kiosk located within their legal jurisdiction.
As you can see KNHBF is well positioned to monetize the cannabis sector from every possible angle!
You would be hard pressed to find a company better positioned for growth in this multi billion dollar market than KNHBF.
Recent Developments:
International Cannabis Increases European Distribution Footprint by Over 1,300 Pharmacies
Last week, the Company announced that its exclusive European distribution partner, Cosmos Holdings, Inc. (“Cosmos”), has acquired Greek pharmaceutical wholesaler, Cosmofarm Ltd. (“Cosmofarm”).
Established in 1994, Athens based Cosmofarm provides a comprehensive range of pharmaceutical products to over 1,130 pharmacies. Cosmofarm has been authorized and endorsed by Greece’s National Organization for Medicines under Good Distribution Practices to distribute over-the-counter pharmaceuticals, natural and health food supplements, as well as branded and generic medicines.
Cosmofarm is equipped with an extensive supplier network of approximately 250 pharmaceutical manufacturers and realized sales of nearly US$14 million for the fiscal year 2017. Cosmofarm is in the process of relocating its operations to a new 32,000 square foot facility, increasing its manufacturing capacities by 2,000%. The facility’s state-of-the-art manufacturing operations include a robotic fulfillment center and will significantly improve Cosmofarm’s scaling and distribution capabilities.
Eugene Beukman, chief executive officer and a director of International Cannabis, stated: “International Cannabis applauds the acquisition of Cosmofarm, which further augments the Company’s robust European distribution capabilities. Cosmofarm is a rapidly growing wholesaler with embedded shared-values of innovation and high-quality distribution. This transaction is once again demonstrative of International Cannabis’ mandate of creating sustainable shareholder value, through the strategic acquisition of revenue generating assets. The Company will leverage Cosmofarm’s distribution channels and robotic fulfillment centre to facilitate its growing pipeline of purchase orders in 2019”.
International Cannabis will market and sell its cannabis and cannabidiol (“CBD”) products throughout the 28 eligible member states of the European Union (“EU”). The EU has over 500 million potential consumers, affording International Cannabis a unique opportunity to service this high-growth marketplace.
Furthermore, the Company plans further leverage Cosmofarm’s 32,000 square foot facility to manufacture and distribute white-labeled CBD products from its Greek industrial hemp cultivation operations. International Cannabis controls three hemp licenses spanning a total of 16 acres situated within the Greek prefecture of Imathia. These licenses permit the Company cultivate, manufacture, distribute and export industrial hemp and its many CBD derived extracts. Greece boasts over 300 days of unadulterated sunshine per year, resulting in attractive climate for outdoor industrial hemp cultivation.
International Cannabis will leverage Cosmos Holdings Inc.'s robust distribution network, representing approximately 36,130 pharmacies to market and sell its cannabis and CBD products. The Company, through its wholly owned subsidiary Marathon Global Inc., has an exclusive agreement with Cosmos, a European-based pharmaceutical distributor.
Cosmos has a trans-European network of over 160 clients and vendors, which expands to 16 countries, including: Germany, United Kingdom, Ireland, United Arab Emirates, Denmark, Italy, France, Singapore, Spain, Lebanon, Skopje, Jordan, Sweden, Poland, the Netherlands and Greece. This European distribution network is augmented by various value-added services, including strategic procurement, warehousing, product registrations and regulatory representations.
International Cannabis, through its subsidiaries, has agreements in place for European-based pharmaceutical distribution, wholesale importation, and research and development, as well as licenses to cultivate, produce, distribute, store and export cannabis, cannabis derivatives and industrial hemp in Colombia, Denmark, Poland, Greece, Portugal, Poland, Macedonia, Bulgaria, South Africa and the Kingdom of Lesotho.
Market Outlook
Marijuana: A $75 Billion Market by 2030?
This investment bank just increased its sales forecast for the cannabis industry by 50%.
It's also a market that's expected to see continued robust sales growth. ArcView pegged North American legal-weed growth at 33% last year, to $9.7 billion, and it's forecasted $47 billion in annual sales in a decade's time. Yet even this aggressive estimate may undercut the true potential of the cannabis industry.
The hemp-derived CBD market is forecast to be especially lucrative, and a 2017 report by Brightfield Group – a cannabis & CBD market research organization – predicted a per annum increase of 55% over the next five years alone.
The Marijuana Industry Could be Much Bigger Than You Realize
According to a new note published this past week by investment firm Cowen, the total cannabis market could generate as much as $75 billion in gross annual sales by 2030, up from a previous forecast of $50 billion by 2026.
The investment bank's initial forecast was released in September 2016 via a 110-page report from beverage, tobacco, and cannabis sector analyst Vivien Azer and her team. The report, "The Cannabis Compendium: Cross-Sector Views on a Budding Industry," highlighted the many potential applications of legal cannabis and outlined pathways that would allow the weed industry to reach $50 billion in sales by 2026. Chief to that thesis is the expected legalization of marijuana in the U.S. at some point before 2026.
The investment bank's new note lifts its projected sales estimate by another 50% ($25 billion), while adding on just four additional years. Cowen offered six reasons behind its decision to become even more bullish on the outlook for marijuana. Chief among them was proprietary data on binge-drinking statistics among U.S. states that showed a notable decline in binge drinking below the national average in states that had legalized cannabis. It's Cowen's assumption that as more states legalize pot, binge-drinking rates would be expected to fall as consumers opt for cannabis in place of alcohol.
Additionally, Cowen finds that the cannabis market is already worth about $50 billion, albeit with black-market channels being accounted for. If you factor in per-capita spending of $1,500 a year, 50% higher than it previously forecast, along with 35 million annual cannabis users, you can see where the bulk of this $25 billion annual increase from its 2016 projections is coming from.
Cowen even suggests that the United States' fight against the opioid epidemic could lead to an increase in cannabis consumption. Per the report, "Newly published research reinforces the work that we have already done, showing that for some, cannabis is an effective opioid substitute (in particular in treating chronic pain)."
Technical Analysis
KNHBF has never looked more attractive.
Yesterday's ten percent drop in price just created the ultimate "buy the dip" opportunity for our members.
KNHBF's RSI is hovering just above oversold levels, and we believe that a major bullish reversal is in the making.
We also know how fast this stock can move from first hand experience.
When we last brought it to your attention, shares of KNHBF made intraday swings as high as +57.39%!
A run back to its 52-week of $0.90 would show our members up to +260% in pure profit!
Don't miss out on KNHBF's next potential +100% rally!
This is our last trade idea of 2018! And we plan on ending the year on a high note.
As such, we are urging all members to act fast, start their research on KNHBF, and be ready to take action at 9:30AM EST!
(*Remember to use a Stop-Loss Order or basic Limit Order to protect your gains, as well as limit possible losses.)
Best Regards,
The PennyStock101 Team
Don't Miss Our Next Huge Winner...
Text 'PS101' to '67076'
to have our Trade Alerts
Delivered Direct
to your Cell Phone.
(There is no charge.
Msg&data rates may apply.)
DISCLAIMER
This newsletter is a paid advertisement, not a recommendation nor an offer to buy or sell securities. This newsletter is owned, operated and edited by both MJ Capital, LLC and PennyStockLocks, LLC. Any wording found in this e-mail or disclaimer referencing to “I” or “we” or “our” refers to MJ Capital, LLC and PennyStockLocks, LLC. Our business model is to be financially compensated to market and promote small public companies. By reading our newsletter and our website you agree to the terms of our disclaimer, which are subject to change at any time. We are not registered or licensed in any jurisdiction whatsoever to provide investing advice or anything of an advisory or consultancy nature, and are therefore are unqualified to give investment recommendations. Always do your own research and consult with a licensed investment professional before investing. This communication is never to be used as the basis of making investment decisions, and is for entertainment purposes only. At most, this communication should serve only as a starting point to do your own research and consult with a licensed professional regarding the companies profiled and discussed. Conduct your own research. Companies with low price per share are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold our site, its editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters or on our website.
We do not advise any reader take any specific action. Losses can be larger than expected if the company experiences any problems with liquidity or wide spreads. Our website and newsletter are for entertainment purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter and on our website may be based on end-of-day or intraday data. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. If we own any shares we will list the information relevant to the stock and number of shares here. MJ Capital does NOT own any shares of the companies mentioned herewithin, nor intends to buy any in the future.
MJ Capital’s business model is to receive financial compensation to promote public companies. We have been compensated ten thousand dollars by ICC International Cannabis Corp. to conduct investor relations advertising and marketing for KNHBF. We have been previously compensated ten thousand dollars by ICC International Cannabis Corp. to conduct investor relations advertising and marketing for KNHBF-which has expired. Any compensation is a major conflict of interest in our ability to be unbiased. Therefore, this communication should be viewed as a commercial advertisement only. We have not investigated the background of the hiring third party or parties. The third party, profiled company, or their affiliates likely wish to liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices. Any non-compensated alerts are purely for the purpose of expanding our database for the benefit of our future financially compensated investor relations efforts. Frequently companies profiled in our alerts may experience a large increase in volume and share price during the course of investor relations marketing, which may end as soon as the investor relations marketing ceases. The investor relations marketing may be as brief as one day, after which a large decrease in volume and share price is likely to occur. Our emails may contain forward looking statements, which are not guaranteed to materialize due to a variety of factors.
We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters and on our website is believed to be accurate and correct, but has not been independently verified and is not guaranteed to be correct. The information is collected from public sources, such as the profiled company’s website and press releases, but is not researched or verified in any way whatsoever to ensure the publicly available information is correct. Furthermore, MJ Capital often employs independent contractor writers who may make errors when researching information and preparing these communications regarding profiled companies. Independent writers’ works are double-checked and verified before publication, but it is certainly possible for errors or omissions to take place during editing of independent contractor writer’s communications regarding the profiled company(s). You should assume all information in all of our communications is incorrect until you personally verify the information, and again are encouraged to never invest based on the information contained in our written communications. The information in our disclaimers is subject to change at any time without notice.
Metronome - 14mm usd cap "Gem" with Bitcoin Core Dev CreatorMetronome (www.metronome.io) is a built to last cryptocurrency originally created by Bloq, headed by Jeff Garzik (core bitcoin developer).
It has a unique auction mechanism that controls inflation of the money supply and built in converter contracts that provide liquidity in wallet in either direction (think a mini bancor). The converter contract currently has ~4000 eth of buyside liquidity and 500k metronome in sellside liquidity. This liquidity shifts based on the day's auction price.
Metronome is self governing and portable... meaning that users will soon be able to move their tokens in between blockchains. Because of this, metronome will survive forever.
Metronome is intended as a store of value.
From a technical perspective, we can see that Metronome has broken its horizontal range.
I believe this project is extremely undervalued from a fundamental perspective and am targeting 100million -250million usd market cap to sell.
Idex seems to be the most liquid place to purchase, but it's available in the Metronome wallet as well as Bittrex and other exchanges.
DYOR and feel free to join their telegram. They are very helpful.
Long HeinekenStock has been undervalued for far too long. Nice opportunity for a buy, especially considering the divergence on the RSI and the oversold area of both the RSI and MFI. Solid company with solid financials.
MNKD - Next Resistance Level 1.5, or Reversal of DownTrendLooking for a resistance level that causes a reversal of trend. You can see the 2.01 resistance level was hit on 9/6, and 9/7 the price fell through to 1.78. If the downward trend continues, the next resistance level to be hit would be 1.5. Substantial sell volume on 9/5, 9/6 and 9/7 could be indicative of a higher likelihood for a trend reversal early next week.
According to Chris Lau at InvestorPlace, a 10 yr discounted cash flow revenue exit model values shares at an average of $2.40, placing the stock at a current discount of 20/25%, assuming revenue increases due to the new partnership with UTHR.
finance.yahoo.com
The most important chart in Bitcoin: Metcalfe's lawSorry, I didn't know how to do it here on tradingview.
My very smart girlfriend Jixuan Wang used the program R to import and plot the real bitcoin price versus the Metcalfe price:
ibb.co
Orange is real price from exchanges, green is Metcalfe price, which can be calculated from the number of the daily transactions squared:
P = C* T².
P=price
C= a constant, chosen such that the fit is good
T = number of daily transactions
If orange above green: BTC IS OVERPRICED
If green above orange: BTC IS UNDERPRICED
We are currently overpriced, same as in 2014/2015. This is one of the main reasons why I believe that this bearmarket will still go on for 1 more year.
